Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL PIPERAZINE COMPOUND OR THE SALT THEREOF FOR USE AS PESTICIDES
Document Type and Number:
WIPO Patent Application WO/2022/070023
Kind Code:
A1
Abstract:
An object of the present disclosure is to provide a piperazine compound or the salt thereof that controls pests. The present disclosure provides a piperazine compound represented by Formula (I), or a salt thereof, wherein R1 represents a hydrogen atom, or the like. R2 represents a hydrogen atom, or the like. R3 represents a hydrogen atom, or the like. R4, R5, R6, R7, R8, R9, R10 and R11 independently represent a hydrogen group, or the like. R4 and R10, or R6 and R8 may be taken together to form a substituted or unsubstituted C1-C3 alkylene group. Ar represents a substituted or unsubstituted aryl group, or the like. X represents an oxygen atom, or the like. R15 represents a hydrogen atom, or the like. Q represents an oxygen atom, or a sulfur atom. m represents an integer of 0 to 5; when m is 2 or more, R3 may be the same or different. n represents the number of CH2 and represents an integer of 0 to 1.

Inventors:
SURAMWAR NIKHIL (IN)
KHOLE SAURABH ARUN (IN)
LAHARE UMESH SONYABAPU (IN)
BABAR KIRAN SADASHIV (IN)
YADAV MANISH KUMAR (IN)
SHARMA KAMLESH (IN)
SINGH MANISH KUMAR (IN)
MATSUZAKI KOHEI (IN)
Application Number:
PCT/IB2021/058818
Publication Date:
April 07, 2022
Filing Date:
September 28, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
OAT & IIL INDIA LABORATORIES PRIVATE LTD (IN)
International Classes:
C07D401/12; A01N43/60; A01N43/82; C07D401/14; C07D413/14; C07D417/14; C07D471/08
Domestic Patent References:
WO2009036996A22009-03-26
WO2021053161A12021-03-25
WO2020207941A12020-10-15
Foreign References:
EP3456716A12019-03-20
IN202011042327A2020-09-29
Other References:
KUDUK SCOTT D ET AL: "5-Piperazinyl pyridine carboxamide bradykinin B1antagonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 16, no. 10, 10 March 2006 (2006-03-10), pages 2791 - 2795, XP028674512, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2006.01.112
DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 8 May 2016 (2016-05-08), AURORA FINE CHEMICALS: "2 specific phenylamino-pyridine derivatives", XP055878633, retrieved from STN Database accession no. 1906169-00-3
DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 13 May 2016 (2016-05-13), AURORA FINE CHEMICALS: "5 specific phenylamino-pyridine derivatives", XP055878624, retrieved from STN Database accession no. 1906856-02-5
DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 14 April 2011 (2011-04-14), FCH GROUP: "1 phenyloxypyridine derivative", XP055878869, retrieved from STN Database accession no. 1279978-43-6
DATABASE REGISTRY [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 9 October 2009 (2009-10-09), AURORA FINE CHEMICALS: "1 specific phenylsulfonylpyridine derivative", XP055878873, retrieved from STN Database accession no. 1189444-60-7
CAS , no. 129531-12-0
"Technical Mono-graph", 2008, CROPLIFE INTERNATIONAL, article "Catalogue of pesticide formulation types and international coding system"
MOLLETGRUBENMANN: "Formulation technology", 2001, WILEY VCH
KNOWLES: "Agrow Reports DS243", 2005, T F INFORMA, article "New developments in crop protection product formulation"
MCCUTCHEON: "Emulsifiers Detergents, McCutcheon's Directories", vol. 1
Attorney, Agent or Firm:
GARG, Vidisha et al. (IN)
Download PDF:
Claims:
CLAIMS Claim 1: A piperazine compound represented by Formula (I): or a salt thereof, wherein R1 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C3-C8 cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. R2 represents a hydrogen atom, a halogen atom, a cyano group, a carboxyl group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C1-C6 alkylsulfinyl group, a substituted or unsubstituted C1-C6 alkylsulfonyl group, a substituted or unsubstituted C3-C8 cycloalkyl group, a substituted or unsubstituted C1-C6 alkoxycarbonyl group, an aminohydroxyimino group, an aminocarbonyl group, an aminothiocabonyl group, or a substituted or unsubstituted heteroaryl group. R3 represents a hydrogen atom, a halogen atom, a cyano group, a nitro group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C1-C6 alkylsulfinyl group, a substituted or unsubstituted C1-C6 alkylsulfonyl group, a substituted or unsubstituted C2-C6 alkenyl group, a substituted or unsubstituted C2-C6 alkenyloxy group, a substituted or unsubstituted C2-C6 alkynyloxy group, a substituted or unsubstituted C3-C8 cycloalkyl group, a substituted or unsubstituted C1-C6 alkoxycarbonyl group, a substituted or unsubstituted C1-C6 alkylcarbonyloxy group, a substituted or unsubstituted C1-C6 alkylcarbonylthio group, a substituted or unsubstituted C1-C6 alkylsulfonyloxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or a substituted or unsubstituted aryloxy group. R4, R5, R6, R7, R8, R9, R10 and R11 independently represent a hydrogen group, a cyano group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C1-C6 alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. R4 and R10, or R6 and R8 may be taken together to form a substituted or unsubstituted C1-C3 alkylene group. Ar represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. X represents an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or NR14. R14 represents a hydrogen atom, a substituted or unsubstituted C1-C6 alkyl group, or a substituted or unsubstituted C1-C6 alkoxycarbonyl group. R15 represents a hydrogen atom, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. Q represents an oxygen atom, or a sulfur atom. m represents an integer of 0 to 5; when m is 2 or more, R3 may be the same or different. n represents the number of CH2 and represents an integer of 0 to 1. Claim 2: The piperazine compound or the salt thereof according to the preceding claim, wherein the compound is represented by formula (Ia): wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, X, R14, Q and m are same as those defined in the formula (I). R12 and R13 independently represent a hydrogen atom, a halogen atom, a cyano group, a nitro group, an amino group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxycarbonylamino group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C1-C6 alkylsulfinyl group, or a substituted or unsubstituted C1-C6 alkylsulfonyl group. Claim 3: The piperazine compound or the salt thereof according to any one of the preceding claims, wherein R1 is a substituted or unsubstituted C1-C6 alkyl group. Claim 4: The piperazine compound or the salt thereof according to any one of the preceding claims, wherein R2 is a halogen atom, a cyano group, or a carboxyl group, an aminohydroxyimono group, an aminocarbonyl group, an aminothiocarbonyl group, or a substituted or unsubstituted heteroaryl group. Claim 5: The piperazine compound or the salt thereof according atom, a halogen atom, a cyano group, a nitro group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C1-C6 alkylsulfinyl group, a substituted or unsubstituted C1-C6 alkylsulfonyl group, or a substituted or unsubstituted C1-C6 cycloalkyl group. Claim 6: The piperazine compound or the salt thereof according to any one of the preceding claims, wherein R4, R5, R6, R7, R8, R9, R10 and R11 independently represent a hydrogen atom, a cyano group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. Claim 7: The piperazine compound or the salt thereof according to any one of the preceding claims, wherein R4 and R10, or R6 and R8 may be taken together to form ethylene group. Claim 8: The piperazine compound or the salt thereof according to any one of the preceding claims, wherein the compound is represented by a formula (ID): wherein R1 is a substituted or unsubstituted C1-C6 alkyl group, R2 is a cyano group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxycarbonyl group, or a substituted or unsubstituted heteroaryl group, R3 is a halogen atom, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C1-C6 alkylsulfinyl group, or a substituted or unsubstituted C1-C6 alkylsulfonyl group, R4 is a hydrogen atom, or a substituted or unsubstituted C1- C6 alkyl group, R6 is a hydrogen atom, a cyano group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C1-C6 alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, R7 is a hydrogen atom, or a substituted or unsubstituted C1- C6 alkyl group, R8 is a hydrogen atom, or a substituted or unsubstituted C1- C6 alkyl group, R12 is a halogen atom, a cyano group, a nitro group, an amino group, or a substituted or unsubstituted C1-C6 alkoxycarbonylamino group, R13 is a hydrogen atom, a halogen, a nitro group, an amino group, or a substituted or unsubstituted C1-C6 alkyl group, and Q is an oxygen atom or a sulfur atom. Claim 9: The piperazine compound or the salt thereof according to claim 8, wherein R1 is a substituted or unsubstituted C1-C6 alkyl group, R2 is a cyano group, R3 is a substituted or unsubstituted C1-C6 alkoxy group, or a R4 is a hydrogen atom, or a substituted or unsubstituted C1- C6 alkyl group, R6 is a hydrogen atom, or a substituted or unsubstituted C1- C6 alkyl group, R7 is a hydrogen atom, R8 is a hydrogen atom, R12 is a halogen atom, R13 is a halogen atom, and Q is an oxygen atom. Claim 10: A pest controlling agent comprising the piperazine compound or a salt thereof as an active ingredient according to any one of the preceding claims. Claim 11: A method for using the piperazine compound or a salt thereof according to any one of the preceding claims for controlling pests. Claim 12: A method for controlling pests, which comprises applying the piperazine compound or a salt thereof according to any one of the preceding claims to a plant or its vicinity, or soil where a plant is cultivated. Claim 13: A method for controlling pests, which comprises applying an effective amount of the piperazine compound or a salt thereof according to any one of the preceding claims to pests, a habitat of pests, or a place where inhabitation is predicted.
Description:
DESCRIPTION Title of Invention: NOVEL PIPERAZINE COMPOUND OR THE SALT THEREOF Technical Field The present disclosure relates to a novel piperazine compound or a salt thereof. Background Art In recent years, use of some insecticidal or miticidal agents is restricted due to environmental pollution and gradual accumulation of residual pesticides in the environment. Due to the emergence of mite resistance to conventional miticides in recent years as a result of long-term use of such miticides, it has become difficult to accomplish control by use of known miticides. Therefore, it is urgent to develop novel miticides which are thought to have different actions from commercially available miticides. Citation List Patent Literatures PLT 1 WO2011/078081 PLT 2 WO2017/195703 PLT 3 WO2015/032280 Summary of the Invention Solution to Problem The present disclosure provides a piperazine compound or a salt thereof which has an excellent effect not only on adult mites but also on eggs or ova. The present disclosure also provides a piperazine compound or a salt thereof which has an excellent controlling effect against mites and/or ova even when used at a low concentration. The present disclosure further provides a piperazine compound or a salt thereof having a high controlling effect on mites and/or ova which have acquired resistance to existing miticides. Specifically, as a result of extensive research, the present inventors have found that a compound represented by the following general formula (I) or a salt thereof exhibits excellent miticidal activity at low concentration. At the same time, the compound represented by the formula (I) also exhibits ovicidal activity against pests for agricultural and horticultural use, particularly against mites typified by the two-spotted spider mite, the citrus red mite and Kanzawa spider mite. Thus, the present disclosure relates to a novel piperazine compound represented by the following general formula (I) or a salt thereof. More specifically, the present disclosure includes the following embodiments: Item 1: A piperazine compound represented by Formula (I): or a salt thereof, wherein R 1 represents a hydrogen atom, a halogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 3 -C 8 cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. R 2 represents a hydrogen atom, a halogen atom, a cyano group, a carboxyl group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, a substituted or unsubstituted C 3 -C 8 cycloalkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, an aminohydroxyimino group, an aminocarbonyl group, an aminothiocabonyl group, or a substituted or unsubstituted heteroaryl group. R 3 represents a hydrogen atom, a halogen atom, a cyano group, a nitro group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, a substituted or unsubstituted C 2 -C 6 alkenyl group, a substituted or unsubstituted C 2 -C 6 alkenyloxy group, a substituted or unsubstituted C 2 -C 6 alkynyl group, a substituted or unsubstituted C 2 -C 6 alkynyloxy group, a substituted or unsubstituted C 3 -C 8 cycloalkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, a substituted or unsubstituted C 1 -C 6 alkylcarbonyloxy group, a substituted or unsubstituted C 1 -C 6 alkylcarbonylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfonyloxy group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, or a substituted or unsubstituted aryloxy group. R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 independently represent a hydrogen group, a cyano group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. R 4 and R 10 , or R 6 and R 8 may be taken together to form a substituted or unsubstituted C 1 -C 3 alkylene group. Ar represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. X represents an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or NR 14 . R 14 represents a hydrogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, or a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group. R 15 represents a hydrogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. Q represents an oxygen atom, or a sulfur atom. m represents an integer of 0 to 5; when m is 2 or more, R 3 may be the same or different. n represents the number of CH 2 and represents an integer of 0 to 1. Item 2: The piperazine compound or the salt thereof according to the preceding item, wherein the compound is represented by a formula (Ia): wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , X, R 14 , Q and m are R 12 and R 13 independently represent a hydrogen atom, a halogen atom, a cyano group, a nitro group, an amino group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonylamino group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group. Item 3: The piperazine compound or the salt thereof according to any one of the preceding items, wherein R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group. Item 4: The piperazine compound or the salt thereof according to any one of the preceding items, wherein R 2 is a halogen atom, a cyano group, a carboxyl group, an aminohydroxyimono group, an aminocarbonyl group, an aminothiocabonyl group, or a substituted or unsubstituted heteroaryl group. Item 5: The piperazine compound or the salt thereof according to any one of the preceding items, wherein R 3 is a hydrogen atom, a halogen atom, a cyano group, a nitro group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, or a substituted or unsubstituted C 1 -C 6 cycloalkyl group. Item 6: The piperazine compound or the salt thereof according to any one of the preceding items, wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 each independently represent a hydrogen atom, group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. Item 7: The piperazine compound or the salt thereof according to any one of the preceding items, wherein R 4 and R 10 , or R 6 and R 8 may be taken together to form ethylene group. Item 8: The piperazine compound or the salt thereof according to any one of the preceding items, wherein the compound is represented by formula (ID): wherein R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group, R 2 is a cyano group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, or a substituted or unsubstituted heteroaryl group, R 3 is a halogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, R 4 is a hydrogen atom, or a substituted or unsubstituted C 1 - C 6 alkyl group, R 6 is a hydrogen atom, a cyano group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, R 7 is a hydrogen atom, or a substituted or unsubstituted C 1 - C 6 alkyl group, R 8 is a hydrogen atom, or a substituted or unsubstituted C 1 - C 6 alkyl group, R 12 is a halogen atom, a cyano group, a nitro group, an amino group, or a substituted or unsubstituted C 1 -C 6 alkoxycarbonylamino group, R 13 is a hydrogen atom, a halogen, a nitro group, an amino group, or a substituted or unsubstituted C 1 -C 6 alkyl group, and Q is an oxygen atom or a sulfur atom. Item 9: The piperazine compound or the salt thereof according to any one of the preceding items, wherein the compound is represented by formula (ID): wherein R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group, R 2 is a cyano group, R 3 is a substituted or unsubstituted C 1 -C 6 alkoxy group, or a substituted or unsubstituted C 1 -C 6 alkylthio group, R 4 is a hydrogen atom, or a substituted or unsubstituted C 1 - C 6 alkyl group, R 6 is a hydrogen atom, or a substituted or unsubstituted C 1 - C 6 alkyl group, R 7 is a hydrogen atom, R 8 is a hydrogen atom, R 12 is a halogen atom, Q is an oxygen atom. Item 10: A pest controlling agent comprising the piperazine compound or a salt thereof according to any one of the preceding items. Item 10A: A composition for use in pest controlling comprising the piperazine compound or a salt thereof according to any one of the preceding items. Item 10-1: A miticide comprising the piperazine compound or a salt thereof according to any one of the preceding items. Item 10-1A: A composition for use as a miticide comprising the piperazine compound or a salt thereof according to any one of the preceding items. Item 11: A method for using the piperazine compound or a salt thereof according to any one of the preceding items for controlling pests. Item 11A: Use of the piperazine compound or a salt thereof according to any one of the preceding items for controlling pests. Item 11-1: A method for using the piperazine compound or a salt thereof according to any one of the preceding items for controlling mites. Item 11-1A: Use of the piperazine compound or a salt thereof according to any one of the preceding items for controlling mites. Item 12: A method for controlling pests, which comprises applying the piperazine compound or a salt thereof according to any one of the preceding items to a plant or its vicinity, or soil where a plant is cultivated. Item 12-1: A method for controlling mites, which comprises applying the piperazine compound or a salt thereof according to any one of the preceding items to a plant or its vicinity, or soil where a plant is cultivated. Item 13: A method for controlling pests, which comprises applying an effective amount of the piperazine compound or a salt thereof according to any one of the preceding items to pests, a habitat of pests, or a place where inhabitation is predicted. Item 13-1: A method for controlling mites, which comprises applying an effective amount of the piperazine compound or a salt thereof according to any one of the preceding items to mites, a habitat of mites, or a place where inhabitation is predicted. It is intended that one or more of the aforementioned features can be provided as a combination of one or more of the aforementioned features in addition to the explicitly shown combinations. Further embodiments and advantages of the art by reading and understanding the following Detailed Description as needed. Advantageous Effects of Invention According to the present disclosure, it is possible to provide a piperazine compound or a salt thereof having an excellent controlling effect against pests. Especially, according to the present disclosure, the piperazine compound or a salt thereof having an excellent effect not only on adult mites but also on eggs even at low concentrations and a miticide containing these compounds can be provided. Additionally, with the present disclosure, the piperazine compound or a salt thereof having a high controlling effect in a mite which has acquired resistance to an existing miticide and a miticide containing these compounds can be provided. Description of Embodiments Hereinafter, the present disclosure will be described in more details with reference to examples, but the technical scope of the present disclosure is not limited to these examples. Throughout the entire specification, a singular expression should be understood as encompassing the concept thereof in the plural form, unless specifically noted otherwise. Thus, singular articles (e.g., "a", "an", "the" and the like in case of English) should also be understood as encompassing the concept thereof in the plural form unless specifically noted otherwise. Further, the terms used herein should be understood as being used in the meaning that is commonly used in the art, unless specifically noted otherwise. Thus, unless defined otherwise, all terminologies and scientific technical terms that are used herein have the same meaning as the terms commonly understood by those skilled in the art to which the present disclosure pertains. In case of a contradiction, the present specification (including the definitions) takes precedence. [A piperazine compound or a salt thereof] The present disclosure provides a piperazine compound represented by Formula (I): or a salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 15 , Ar, X, Q, n, and m are as defined elsewhere herein. The present disclosure provides a piperazine compound represented by Formula (IA): or a salt thereof, wherein R 1 , R 2 , R 3 , R 12 , R 13 , X, and n are as defined elsewhere herein. In some embodiments, R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 1 is an unsubstituted C 1 -C 6 alkyl group or a C 1 -C 6 haloalkyl group. In some embodiments, R 2 is a cyano group, or a halogen atom. In some embodiments, R 2 is a cyano group. In some embodiments, R 3 is a hydrogen atom, a halogen atom, a nitro group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, or a substituted or unsubstituted C 3 -C 8 cycloalkyl group. In some embodiments, R 3 is a hydrogen atom, a halogen atom, a nitro group, a substituted or unsubstituted C 1 -C 6 group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, or a substituted or unsubstituted C 3 -C 8 cycloalkyl group and is at position 4 relative to -X-(CH 2 ) n - on the benzene ring to which it is attached. In some embodiments, R 12 is a halogen atom, a cyano group, a nitro group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group. In some embodiments, R 12 is a halogen atom. In some embodiments, R 13 is a hydrogen atom, a halogen atom, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 13 is a halogen atom. Insome embodiments, X is an oxygen atom, a sulfur atom, a sulfinyl group, a sulfonyl group, or NR 14 , wherein R 14 represents a hydrogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, or a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group. In some embodiments, X is an oxygen atom, or a sulfur atom. In some embodiments, n is an integer of 0 to 1. In some embodiments, n is 0. The present disclosure provides a piperazine compound represented by Formula (IB): or a salt thereof, wherein R 1 , R 2 , R 3 , R 12 , and R 13 are as defined elsewhere herein. In some embodiments, R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 1 is In some embodiments, R 2 is a halogen atom, or a cyano group. In some embodiments, R 2 is a cyano group. Insome embodiments, R 3 is a halogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, or a substituted or unsubstituted C 1 -C 6 alkylthio group and is at position 4 relative to the oxygen atom on the benzene ring to which it is attached. In some embodiments, R 3 is a substituted or unsubstituted C 1 -C 6 alkyl group or a substituted or unsubstituted C 1 -C 6 alkylthio group and is at position 4 relative to the oxygen atom on the benzene ring to which it is attached. In some embodiments, R 3 is an unsubstituted C 1 - C 6 alkyl group or a C 1 -C 6 haloalkylthio group and is at position 4 relative to the oxygen atom on the benzene ring to which it is attached. In some embodiments, R 12 is a halogen atom, a cyano group, or a substituted or unsubstituted C 1 -C 6 alkylthio group. In some embodiments, R 12 is a halogen atom. In some embodiments, R 13 is a halogen atom. The present disclosure provides a piperazine compound represented by Formula (IC): or a salt thereof, wherein R 1 , R 2 , R 3 , R 12 , and R 13 are as defined elsewhere herein. In some embodiments, R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 1 is an unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 2 is a cyano group. In some embodiments, R 3 is a substituted or unsubstituted C 1 -C 6 alkyl group and is at position 4 relative In some embodiments, R 3 is an unsubstituted C 1 -C 6 alkyl group and is at position 4 relative to the oxygen atom on the benzene ring to which it is attached. In some embodiments, R 12 is a halogen atom. In some embodiments, R 13 is a halogen atom. The present disclosure provides a piperazine compound represented by Formula (ID): or a salt thereof, wherein R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , R 8 , R 12 , R 13 , and Q are as defined elsewhere herein. In some embodiments, R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 1 is an unsubstituted C 1 -C 6 alkyl group. Insome embodiments, R 2 is a cyano group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, or a substituted or unsubstituted heteroaryl group. In some embodiments, R 2 is a cyano group. Insome embodiments, R 3 is a halogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group. In some embodiments, R 3 is a substituted or unsubstituted C 1 -C 6 alkoxy group, or a substituted or unsubstituted C 1 -C 6 alkylthio group. In some embodiments, R 3 is a C 1 -C 6 haloalkoxy group or a C 1 -C 6 haloalkylthio group. In some embodiments, R 4 is a hydrogen atom, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 4 is a hydrogen atom, or an unsubstituted C 1 - C 6 alkyl group. In some embodiments, R 6 is a hydrogen atom, a cyano group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, a substituted or unsubstituted aminocarbonyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group. In some embodiments, R 6 is a hydrogen atom, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 6 is a hydrogen atom, an unsubstituted C 1 -C 6 alkyl group, or an unsubstituted C 1 -C 6 alkoxy-C 1 -C 6 alkyl group. In some embodiments, R 4 is an unsubstituted C 1 -C 6 alkyl group, and R 6 is a hydrogen atom. In some embodiments, R 4 is a hydrogen atom, and R 6 is an unsubstituted C 1 -C 6 alkyl group, or unsubstituted C 1 -C 6 alkoxy-C 1 -C 6 alkyl group. In some embodiments, R 7 is a hydrogen atom, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 7 is a hydrogen atom. In some embodiments, R 8 is a hydrogen atom, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 8 is a hydrogen atom. In some embodiments, R 12 is a halogen atom, a cyano group, a nitro group, an amino group, or a substituted or unsubstituted C 1 -C 6 alkoxycarbonylamino group. In some embodiments, R 12 is a halogen atom. In some embodiments, R 13 is a hydrogen atom, a halogen, a nitro group, an amino group, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 13 is a halogen atom. In some embodiments, Q is an oxygen atom, or a sulfur atom. In some embodiments, Q is an oxygen atom. The present disclosure provides a piperazine compound represented by Formula (IE): or a salt thereof, wherein R 1 , R 3 , R 4 , R 6 , and Ar are as defined elsewhere herein. In some embodiments, R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 1 is an unsubstituted C 1 -C 6 alkyl group. Insome embodiments, R 3 is a halogen atom, a nitro group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group. In some embodiments, R 3 is a substituted or unsubstituted C 1 -C 6 alkylthio group and is at position 4 relative to the oxygen on the benzene ring to which it is attached. In some embodiments, R 3 is a C 1 -C 6 haloalkylthio group and is at position 4 relative to the oxygen on the benzene ring to which it is attached. In some embodiments, R 4 is a hydrogen atom, or a substituted or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 4 is a hydrogen atom, or unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 6 is a hydrogen atom, or a substituted or an unsubstituted C 1 -C 6 alkyl group. In some embodiments, R 6 is a hydrogen atom. In some embodiments, Ar is a substituted or unsubstituted heteroaryl group. In some embodiments, Ar is 1,2,4-oxadiazol-3-yl substituted with a C 1 -C 6 alkyl group. The following shows specific examples of each group as used in this specification. The term "unsubstituted" in this description means that a base group is the only group constituting the group. group has the meaning of being "unsubstituted" when the group is not described as being "substituted" and described using the name of the base group. On the other hand, the term "substituted" means that any of hydrogen atoms of the base group are substituted with a group that is not a hydrogen atom and is the same as or different from the base group. The "substituted" group may be substituted with one substituent, or two or more substituents. The two or more substituents may be the same or different. Further, a base group may be substituted with one or more substituents, which may be the same or different from each other. The "substituent" is not particularly limited as long as it is chemically permissible and achieves the effects of the present disclosure. Examples of the "substituent" include a halogen atom such as a fluorine atom, chlorine atom, bromine atom, iodine atom or the like; a C 1 -C 6 alkyl such as a methyl, ethyl, n- propyl, isopropyl, n-butyl, s-butyl, isobutyl, t-butyl, n- pentyl, n-hexyl or the like; a C 3 -C 8 cycloalkyl such as a cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or the like; a C 2 -C 6 alkenyl such as a vinyl, 1- propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1- methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2- pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-2-butenyl, 2- methyl-2-butenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl or the like; a C 3 -C 8 cycloalkenyl such as a 2- cyclopropenyl, 2-cyclopentenyl, 3-cyclohexenyl, 4- cyclooctenyl or the like; a C 2 -C 6 alkynyl such as an ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1- methyl-2-propynyl, 2-methyl-3-butynyl, 1-pentynyl, 2- pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 2- methyl-3-pentynyl, 1-hexynyl, 1,1-dimethyl-2-butynyl or the like; a C 1 -C 6 alkoxy such as a methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, s-butoxy, isobutoxy, t-butoxy or the 1-en-1-yloxy, but-1-en-1-yloxy, but-2-en-1-yloxy, but-3-en- 1-yloxy or the like; a C 2 -C 6 alkynyloxy such as an ethynyloxy, propargyloxy or the like; a C 6- C 10 aryl such as a phenyl, naphthyl or the like; a C 6 -C 10 aryloxy such as a phenoxy, 1- naphthoxy or the like; a C 7 -C 11 aralkyl such as a benzyl, phenethyl or the like; a C 7 -C 11 aralkoxy such as a benzyloxy, phenethyloxy or the like; a C 1 -C 7 acyl such as a formyl, acetyl, propionyl, benzoyl, cyclohexyl carbonyl or the like; a C 1 -C 7 acyloxy such as a formyloxy, acetyloxy, propionyloxy, benzoyloxy, cyclohexyl carbonyloxy or the like; a C 1 -C 6 alkoxycarbonyl such as a methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, t- butoxycarbonyl or the like; a C 1 -C 6 alkylcarbonyl such as a methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, n-butylcarbonyl, isobutylcarbonyl, sec- butylcarbonyl, tert-butylcarbonyl or the like; a carboxyl; a hydroxy; an oxo; a C 1 -C 6 haloalkyl such as a chloromethyl, chloroethyl, trifluoromethyl, 1,2-dichloro-n-propyl, 1- fluoro-n-butyl, perfluoro-n-pentyl or the like; a C 2 -C 6 haloalkenyl such as a 2-chloro-1-propenyl, 2-fluoro-1- butenyl or the like; a C 2 -C 6 haloalkynyl such as a 4,4- dichloro-1-butynyl, 4-fluoro-1-pentynyl, 5-bromo-2-pentynyl or the like; a C 1 -C 6 haloalkoxy such as a 2-chloro-n-propoxy, 2,3-dichlorobutoxy or the like; a C 2 -C 6 haloalkenyloxy such as a 2-chloropropenyloxy, 3-bromobutenyloxy or the like; a C 2- C 6 haloalkynyloxy such as a 2-chloropropynyloxy, 3- bromobutynyloxy or the like; a C 6 -C 10 haloaryl such as a 4- chlorophenyl, 4-fluorophenyl, 2,4-dichlorophenyl or the like; a C 6 -C 10 haloaryloxy such as a 4-fluorophenyloxy, 4- chloro-1-naphthoxy or the like; a halogen-substituted C 1 -C 7 acyl such as a chloroacetyl, trifluoroacetyl, trichloroacetyl, 4-chlorobenzoyl or the like; a cyano; an isocyano; a nitro; an isocyanato; a cyanato; an amino; a C 1 - C 6 alkyl amino such as a methyl amino, dimethyl amino, diethyl amino or the like; a C 6 -C 10 aryl amino such as an such as a benzyl amino, phenyl ethyl amino or the like; a C 1 -C 7 acyl amino such as a formyl amino, acetyl amino, propanoyl amino, butyryl amino, isopropyl carbonyl amino, t- butyl carbonyl amino, t-butylacetyl amino, benzoyl amino or the like; a C 1 -C 6 alkoxycarbonyl amino such as a methoxycarbonyl amino, ethoxycarbonyl amino, n- propoxycarbonyl amino, isopropoxycarbonyl amino or the like; a substituted or unsubstituted aminocarbonyl such as, amino carbonyl, dimethyl aminocarbonyl, phenyl aminocarbonyl, N- phenyl-N-methyl aminocarbonyl or the like; an imino- substituted C 1 -C 6 alkyl such as an iminomethyl, (1- imino)ethyl, (1-imino)-n-propyl or the like; a hydroxyimino- substituted C 1 -C 6 alkyl such as a hydroxyiminomethyl, (1- hydroxyimino)ethyl, (1-hydroxyimino)propyl, methoxyiminomethyl, (1-methoxyimino)ethyl or the like; a mercapto; an isothiocyanato; a thiocyanato; a C 1 -C 6 alkylthio such as a methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, s-butylthio, t-butylthio or the like; a C 2 -C 6 alkenylthio such as a vinylthio, allylthio or the like; a C 2 -C 6 alkynylthio such as an ethynylthio, propargylthio or the like; a C 6 -C 10 arylthio such as a phenylthio, naphthylthio or the like; a heterocyclylthio such as a thiazolylthio, pyridylthio or the like; a C 7- C 11 aralkylthio such as a benzylthio, phenethylthio or the like; a (C 1 -C 6 alkylthio)carbonyl such as a (methylthio)carbonyl, (ethylthio)carbonyl, (n-propylthio)carbonyl, (isopropylthio)carbonyl, (n-butylthio)carbonyl, (isobutylthio)carbonyl, (s-butylthio)carbonyl, (t-butyl thio)carbonyl or the like; a C 1 -C 6 alkyl sulfinyl such as methyl sulfinyl, ethyl sulfinyl, t-butyl sulfinyl or the like; a C 2 -C 6 alkenyl sulfinyl such as an allyl sulfinyl or the like; a C 2 -C 6 alkynyl sulfinyl such as a propargyl sulfinyl or the like; a C 6 -C 10 aryl sulfinyl such as a phenyl sulfinyl or the like; a heterocyclyl sulfinyl such as a thiazolyl sulfinyl, pyridyl sulfinyl or the like; a C 7 -C 11 sulfinyl or the like; a C 1 -C 6 alkyl sulfonyl such as a methyl sulfonyl, ethyl sulfonyl, t-butyl sulfonyl or the like; a C 2 -C 6 alkenyl sulfonyl such as an allyl sulfonyl or the like; a C 2 -C 6 alkynyl sulfonyl such as a propargyl sulfonyl or the like; a C 6 -C 10 aryl sulfonyl such as a phenyl sulfonyl or the like; a heterocyclyl sulfonyl such as a thiazolyl sulfonyl, pyridyl sulfonyl or the like; a C 7 -C 11 aralkyl sulfonyl such as a benzyl sulfonyl, phenethyl sulfonyl or the like; a 5- membered heteroaryl such as a pyrrolyl, furyl, thienyl group, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl or the like; a 6-membered heteroaryl such as a pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl or the like; a saturated heterocyclyl such as an aziridinyl, epoxy, pyrrolidinyl, tetrahydrofuranyl, piperidyl, piperazinyl, morpholinyl or the like; a tri C 1 -C 6 alkyl- substituted silyl such as a trimethyl silyl, triethyl silyl, t-butyl dimethyl silyl or the like; a triphenyl silyl or the like; or the like. Examples of halogen include, but are not particularly limited to, fluorine, chlorine, bromine, iodine, and the like. Examples of C 1 -C 6 alkyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain alkyl, such as methyl, ethyl, n-propyl, isopropyl, n- butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, n-octyl and the like. Examples of a substituted C 1 -C 6 alkyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkyl substituted by one or more of above- mentioned substituents, such as C 1 -C 6 haloalkyl, and the like. Examples of C 1 -C 6 haloalkyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain haloalkyl, such as fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, dichloromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2- difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2,2,3,3- tetrafluoropropyl, 3,3-difluoropropyl, 2,3,3- trifluoropropyl, 3,3,3-trifluoropropyl, 2,2,3,3,3- pentafluoropropyl, heptafluoropropyl, 4,4-difluorobutyl, 4,4,4-trifluorobutyl, 3,4,4-trifluorobutyl, 3,3,4,4- tetrafluorobutyl, 3,3,4,4,4-pentafluorobutyl, heptafluoroisobutyl, nonafluorobutyl and the like. Examples of C 1 -C 6 alkoxy include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain alkoxy, such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, and the like. Examples of a substituted C 1 -C 6 alkoxy include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkoxy substituted by one or more of above- mentioned substituents, such as C 1 -C 6 haloalkoxy, and the like. Examples of C 1 -C 6 haloalkoxy include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain haloalkoxy, such as fluoromethoxy, chloromethoxy, bromomethoxy, iodomethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, pentafluoroethoxy, 3,3,3-trifluoropropoxy, 4,4,4-trifluorobutoxy, heptafluoroisobutoxy, and the like. Examples of C 1 -C 6 alkylthio include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain alkylthio, such as methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio, tert-butylthio, and the like. Examples of a substituted C 1 -C 6 alkylthio include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkylthio substituted by one or more of above- mentioned substituents, such as C 1 -C 6 haloalkylthio, and the Examples of C 1 -C 6 haloalkylthio include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain haloalkylthio, such as fluoromethylthio, chloromethylthio, bromomethylthio, iodomethylthio, dichloromethylthio, trichloromethylthio, difluoromethylthio, trifluoromethylthio, chlorodifluoromethylthio, bromodifluoromethylthio, dichlorofluoromethylthio, 2,2,2- trichloroethylthio, 2,2,2-trifluoroethylthio, pentafluoroethylthio, and the like. Examples of C 1 -C 6 alkylsulfinyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain alkylsulfinyl, such as methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl, isobutylsulfinyl, sec-butylsulfinyl, tert-butylsulfinyl, and the like. Examples of a substituted C 1 -C 6 alkylsulfinyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkylsulfinyl substituted by one or more of above-mentioned substituents, such as C 1 -C 6 haloalkylsulfinyl, and the like. Examples of C 1 -C 6 haloalkylsulfinyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain haloalkylsulfinyl, such as fluoromethylsulfinyl, chloromethylsulfinyl, bromomethylsulfinyl, iodomethylsulfinyl, dichloromethylsulfinyl, trichloromethylsulfinyl, difluoromethylsulfinyl, trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfinyl, dichlorofluoromethylsulfinyl, 2,2,2-trichloroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, pentafluoroethylsulfinyl, and the like. Examples of C 1 -C 6 alkylsulfonyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain alkylsulfonyl, such as methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, sec-butylsulfonyl, tert-butylsulfonyl, and the like. Examples of a substituted C 1 -C 6 alkylsulfonyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkylsulfonyl substituted by one or more of above-mentioned substituents, such as C 1 -C 6 haloalkylsulfonyl, and the like. Examples of C 1 -C 6 haloalkylsulfonyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain haloalkylsulfonyl, such as fluoromethylsulfonyl, chloromethylsulfonyl, bromomethylsulfonyl, iodomethylsulfonyl, dichloromethylsulfonyl, trichloromethylsulfonyl, difluoromethylsulfonyl, trifluoromethylsulfonyl, chlorodifluoromethylsulfonyl, bromodifluoromethylsulfonyl, dichlorofluoromethylsulfonyl, 2,2,2-trichloroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, pentafluoroethylsulfonyl, and the like. Examples of C 3 -C 8 cycloalkyl include, but are not particularly limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and the like. Examples of C 2 -C 6 alkenyl include, but are not particularly limited to, C 2 -C 6 straight-chain or branched- chain alkenyl, such as vinyl, allyl, 2-butenyl, 3-butenyl, 1-methylallyl, and the like. Examples of C 2 -C 6 alkenyloxy include, but are not particularly limited to, C 2 -C 6 straight-chain or branched- chain alkenyloxy, such as vinyloxy, 1-propenyloxy, isopropenyloxy, allyloxy, 2-butenyloxy, 3-butenyloxy, 1- methylallyloxy, and the like. Examples of C 2 -C 6 alkynyl include, but are not particularly limited to, C 2 -C 6 straight-chain or branched- chain alkynyl, such as ethynyl, 2-propynyl (propargyl), 1- methyl-2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, and the Examples of C 2 -C 6 alkynyloxy include, but are not particularly limited to, ethynyloxy, 2-propynyloxy, 1- methyl-2-propynyloxy, 1,1-dimethyl-2-propynyloxy, 1- butynyloxy, 2-butynyloxy, 3-butynyloxy, and the like. Examples of C 1 -C 6 alkoxycarbonyl include, but are not particularly limited to, C 1 -C 6 straight-chain or branched- chain alkoxycarbonyl, such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n- butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl, and the like. Examples of C 1 -C 6 alkoxycarbonyloxy include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkoxycarbonyloxy, such as methoxycarbonyloxy, ethoxycarbonyloxy, n-propyloxycarbonyloxy, isopropyloxycarbonyloxy, n-butyloxycarbonyloxy, isobutyloxycarbonyloxy, sec-butyloxycarbonyloxy, tert- butyloxycarbonyloxy, and the like. Examples of C 1 -C 6 alkoxysulfonyloxy include, but are not particularly limited to, C 1 -C 6 straight-chain or branched-chain alkoxysulfonyloxy, such as methoxysulfonyloxy, ethoxysulfonyloxy, n-propyloxysulfonyloxy, isopropyloxysulfonyloxy, n-butyloxysulfonyloxy, isobutyloxysulfonyloxy, sec-butyloxysulfonyloxy, tert- butyloxysulfonyloxy, and the like. Examples of aryl include, but are not particularly limited to, a monocyclic or polycyclic aromatic hydrocarbon, such as phenyl, 1-naphthyl, 2-naphthyl, and the like. Examples of heteroaryl include, but are not particularly limited to, an aromatic heterocyclic group which has at least one of nitrogen, oxygen, and/or sulfur atoms in the ring and may be bonded at any substitutable position, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from N, O and S, such as thienyl, furyl, pyrrolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, isoindolyl, indazolyl, quinazolinyl, carbazolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, quinolinyl, isoquinolinyl, pyridoindolyl, cinnolinyl, phthalazinyl, quinoxalinyl, purinyl, phenothiazinylfuranyl, benzofuranyl, chromanyl, benzothienyl, and the like. Examples of aryloxy include, but are not particularly limited to, phenoxy, 1-naphtoxy, 2-naphtoxy, and like. All the aryls and heteroaryls, mentioned above may optionally be further substituted. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5). Examples of a substituted aryl include, but are not particularly limited to, aryl substituted by one or more of above-mentioned substituents, such as C 1 -C 6 alkyl-substituted aryl, halogen-substituted aryl, C 1 -C 6 haloalkyl-substituted aryl, C 1 -C 6 alkylthio-substituted aryl, cyano-substituted aryl, hydroxy-substituted aryl, formyl-substituted aryl, C 1- C 6 alkylcarbonyl-substituted aryl, and the like. Examples of a substituted heteroaryl include, but are not particularly limited to, heteroaryl substituted by one or more of above-mentioned substituents, such as C 1 -C 6 alkyl- substituted heteroaryl, halogen-substituted heteroaryl, C 1 - C 6 haloalkyl-substituted heteroaryl, C 1 -C 6 alkylthio- substituted heteroaryl, cyano-substituted heteroaryl, hydroxy-substituted heteroaryl, formyl-substituted heteroaryl, C 1- C 6 alkylcarbonyl-substituted heteroaryl, and the like. Examples of C 1 -C 3 alkylene include, but are not particularly limited to, methylene, ethylene, propylene, and the like. Examples of a substituted or unsubstituted aminocarbonyl include, but are not particularly limited to, aminocarbonyl, N-methylaminocarbonyl, N-ethylaminocarbonyl, N-2,2,-difluoroethylaminocarbonyl, N-phenylaminocarbonyl, N,N-dimethylaminocarbonyl, N-methyl-N-phenylaminocarbonyl, and the like. Examples of a substituted or unsubstituted C 1 -C 6 alkoxycarbonylamino include, but are not particularly limited to, methoxyacarbonylamino, ethoxycarbonylamino, propoxycarbonylamino, isopropoxycarbonylamino, butoxycarbonylamino, t-butoxycarbonylamino, (2,2,2- trifluoroethoxy)carbonylamino, and the like. The salts of the compounds represented by the formula (I) may be any type of salts as long as they are agriculturally acceptable. Examples of the salts include inorganic acid salts, such as a hydrochloride salt, a sulfate salt, a nitrate salt, and the like; organic acid salts, such as an acetate salt, a methanesulfonic acid salt, and the like; alkali metal salts, such as a sodium salt, a potassium salt, and the like; alkaline earth metal salts, such as a magnesium salt, a calcium salt, and the like; quaternary ammonium salts, such as tetramethylammonium, tetraethylammonium, and the like; Among compounds (I) of the present disclosure, a preferable compound is a compound in which R 1 is a substituted or unsubstituted C 1 -C 6 alkyl group, and a more preferable compound (I) is a compound in which R 1 is a methyl group, a difluoromethyl group, or a trifluoromethyl group, particularly more preferred compound (I) is a compound in which R 1 is a methyl group. Among compounds (I) of the present disclosure, a preferable compound is a compound in which R 2 is a halogen atom, a cyano group, a carboxyl group, an aminocarbonyl group, or an aminothiocarbonyl group, and a more preferable compound (I) is a compound in which R 2 is an aminothiocarbonyl group or a cyano group, particularly more preferred compound (I) Among compounds (I) of the present disclosure, a preferable compound is a compound in which R 3 is a halogen atom, a cyano group, a nitro group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, and a more preferable compound (I) is a compound in which R 3 is a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxy group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, particularly more preferred compound (I) is a compound in which R 3 is a trifluoromethlythio group at position 4 relative to -X- (CH 2 ) n - on the benzene ring to which it is attached. Among compounds (I) of the present disclosure, a preferable compound is a compound in which R 4 to R 11 are respectively and independently a hydrogen group, a cyano group, a substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkoxycarbonyl group, an aminocarbonyl group, a substituted or unsubstituted C 1 -C 6 alkylaminocarbonyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, or R 4 and R 10 , or R 6 and R 8 may be taken together to form ethylene group, and a more preferable compound (I) is a compound in which R 4 to R 11 is a substituted or unsubstituted C 1 -C 6 alkyl group, particularly more preferred compound (I) is a compound in which R 4 , R 5 , R 7 , R 8 , R 9 , R 10 and R 11 are a hydrogen group and R 6 is a methoxymethyl group or ethyl group. Among compounds (Ia) of the present disclosure, a preferable compound is a compound in which R 12 and R 13 are respectively and independently a hydrogen atom, a halogen substituted or unsubstituted C 1 -C 6 alkyl group, a substituted or unsubstituted C 1 -C 6 alkylthio group, a substituted or unsubstituted C 1 -C 6 alkylsulfinyl group, or a substituted or unsubstituted C 1 -C 6 alkylsulfonyl group, and a more preferable compound (Ia) is a compound in which R 12 and R 13 are respectively and independently a halogen atom , a nitro group, or a substituted or unsubstituted C 1 -C 6 alkyl group, particularly more preferred compound (I) is a compound in which R 12 is a fluorine and R 13 is chlorine. Among compounds (I) of the present disclosure, a preferable compound is a compound in which R 14 is a hydrogen atom, a C 1 -C 6 alkyl group, or a C 1 -C 6 alkoxycarbonyl group. Among compounds (I) of the present disclosure, a preferable compound is a compound in which R 15 is a hydrogen atom, a substituted or unsubstituted C 1 -C 6 alkyl group, particularly more preferred compound (I) is a compound in which R 15 is a hydrogen group. Among compounds (I) of the present disclosure, a preferable compound is a compound in which Ar is heteroaryl group, and a more preferable compound in which Ar is pyridin- 2-yl group, or 1,2,4-oxadiazol-3-yl group, particularly more preferred compound (I) is a compound in which Ar is 3-fluoro- 5-chloro-pyridine-2-yl. Among compounds (I) of the present disclosure, a preferable compound is a compound in which X is an oxygen atom, a sulfur atom, a sulfinyl group, or a sulfonyl group, and a more preferable compound in which X is an oxygen atom. Among compounds (I) of the present disclosure, a preferable compound is a compound in which Q is an oxygen atom, or sulfur atom, particularly more preferred compound (I) is a compound in which Q is an oxygen atom. Among compounds (I) of the present disclosure, a preferable compound is a compound in which m is 1, 2, or 3, and a more preferable compound is a compound in which m is 1. Among compounds (I) of the present disclosure, a preferable compound is a compound in which n is 0. The term "control" encompasses killing, extermination, reduction, and elimination. For example, "controlling a mite" encompasses killing a mite, exterminating a mite, reducing a mite, and eliminating a mite. As used herein control encompasses killing, extermination, reduction, and elimination of any and all developmental stages of a target (e.g. a mite), such as egg, larva, nymphal stages, pupa if any, adult and the like. The same applies to "control agent" and "controlling agent". Compounds of present disclosure can exist as one or more stereoisomers, and it is understood that any of such stereoisomers or combinations thereof are within the scope of the present disclosure. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomers). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. The compounds of the present disclosure may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form. [Method for preparing piperazine compound or a salt thereof] The piperazine compound represented by Formula (I) of the present disclosure can be readily prepared according to following reaction scheme, but is not limited to these methods.

wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 15 , Ar, X, Q, n, m are as defined elsewhere herein. L represents a methyl group or an ethyl group. W represents a leaving group, and examples of the leaving groups include: a halogen atom such as a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom; a substituted or unsubstituted C 1-6 alkyl sulfonyloxy group; and a substituted or unsubstituted aryl sulfonyloxy group. Step 1-1: Step 1-1 is a step of preparing the compound (XIV) with compound (XI), compound (XII) and compound (XIII) in the presence of a solvent to produce the compound (XIV) [Reaction Scheme 1-1] wherein R 1 , R 2 , R 15 , Q, and L are same as defined elsewhere herein. The aforementioned reaction is performed in an appropriate solvent or without any solvent. When the reaction is carried out in the solvent, no limitations are placed on the solvent as long as the solvent is inactive or substantially inactive with respect to the aforementioned reaction. Examples of such a solvent include: fatty acid or alicyclic hydrocarbon-based solvents such as n-hexane, cyclohexane, n-heptane, and the like; aromatic hydrocarbon- based solvents such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; ether-based solvents such as diethyl ether, tetrahydrofuran(THF), 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; amide-based solvents such as acetonitrile; N,N-dimethylformamide (DMF), N,N- dimethylacetamide, N-methyl-2-pyrrolidone and the like; and sulfoxide-based solvents such as dimethyl sulfoxide (DMSO), sulfolane and the like, preferably THF and DMF. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary. The amount of the solvent to be used is generally 0.5 to 20 equivalents, preferably 0.5 to 10 equivalents, per 1 mol of the compound The aforementioned reaction can be performed under absence or presence of a base. Among the above, the reaction is performed preferably under the presence of the base. As the base, a conventionally known base can widely be used, and examples of the bases include: inorganic bases, including alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, and the like; alkali metal hydrides such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, and the like; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine, and the like; and the like, preferably pyridine, triethyl amine, sodium hydride and sodium methoxide. Any separate one of these bases or a combination of two or more types thereof is used. The amount of the base to be used is generally 1.0 to 5.0 mol, preferably 1.0 to 1.2 mol, per 1 mol of the compound (XII). The amount of compound (XIII) to be used is generally 1.0 to 3.0 mol, preferably 1.0 to 2.0 mol, per 1 mol of the compound (XI). The reaction temperature varies depending on the starting compound or material, the reagent, the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 0 to 120°C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 10 minutes to 48 hours, more preferably from 20 minutes to 24 hours. Step 1-2 is a step of preparing the compound (XV) with the treatment of compound (XIV) and phosphorous oxychloride in the presence of a base and a solvent. [Reaction Scheme 1-2] wherein R 1 , R 2 , R 15 , and Q are as defined elsewhere herein. The aforementioned reaction is performed in an appropriate solvent or without any solvent. When the aforementioned reaction is carried out in the solvent, no limitations are placed on the solvent as long as the solvent is inactive or substantially inactive with respect to the aforementioned reaction. Examples of such a solvent include: fatty acid or alicyclic hydrocarbon-based solvents such as n-hexane, cyclohexane, n-heptane, and the like; aromatic hydrocarbon-based solvents such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether- based solvents such as diethyl ether, THF, 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; acetonitrile, toluene. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary. The amount of the solvent to be used is generally 1.0 to 20 equivalents, preferably 1.0 to 10 equivalents, per 1 mol of the compound (XIV). The amount of phosphorous oxychloride to be used is generally 1.0 to 20.0 mol, preferably 5.0 to 10.0 mol, per 1 mol of the compound (XIV). The reaction temperature varies depending on the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 50 to 150°C. The reaction time varies depending on the compound, the reaction reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 20 minutes to 24 hours, more preferably from 1 to 10 hours. Step 1-3: Step 1-3 is a step of preparing the compound (XVI). Treatment of the compound (XV) with base in the presence or absence of a solvent will produce the compound (XVI). [Reaction Scheme 1-3] wherein R 1 , R 2 , R 15 , and Q are as defined elsewhere herein. A reagent used for the saponification is not particularly limited. As the base, a conventionally known base can widely be used, and examples of the base include: inorganic bases, including alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, and the like; alkali metal hydrides such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, and the like; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine, and the like; and the like, preferably pyridine. Any separate thereof is used. The amount of the base to be used is generally 1.0 to 5.0 mol, preferably 1.0 to 2.0 mol, per 1 mol of the compound (XV). The aforementioned reaction is performed in an appropriate solvent or without any solvent. When the aforementioned reaction is carried out in the solvent, no limitations are placed on the solvent as long as the solvent is inactive or substantially inactive with respect to the aforementioned reaction. Examples of such a solvent include: ether-based solvents such as THF, methanol, ethanol, and DMF; and other protic or aprotic solvent. The amount of the solvent to be used is generally 1.0 to 20 liters, preferably 1.0 to 10 liters, per 1 mol of the compound (XV). The reaction temperature varies depending on the starting compound or material, the reagent, the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 0 to 40°C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 5 minutes to 6 hours. Step 1-4: Step 1-4 is a step of preparing the compound (VIII). Treatment of the compound (XVI) with thionyl chloride or oxalyl chloride will produce the compound (VIII). [Reaction Scheme 1-4] wherein R 1 , R 2 , R 15 , and Q are as defined elsewhere herein. The aforementioned reaction is performed in an aforementioned reaction is carried out in the solvent, no limitations are placed on the solvent as long as the solvent is inactive or substantially inactive with respect to the aforementioned reaction. Examples of such a solvent include: fatty acid or alicyclic hydrocarbon-based solvents such as n-hexane, cyclohexane, n-heptane, and the like; aromatic hydrocarbon-based solvents such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether- based solvents such as diethyl ether, THF, 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; acetonitrile, toluene. The amount of the solvent to be used is generally 1.0 to 20 liters, preferably 1.0 to 10 liters, per 1 mol of the compound (XVI). The amount of thionyl chloride or oxalyl chloride to be used is generally 1.0 to 20.0 equivalents, preferably 5.0 to 10.0 equivalents, per 1 mol of the compound (XVI). The reaction temperature varies depending on the starting compound or material, the reaction reagent, the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 50 to 150°C. The reaction time varies depending on the compound, the reaction reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 20 minutes to 24 hours, more preferably from 1 to 10 hours. Step 1-5: Step 1-5 is a step of preparing the compound (X). Treatment of the compound (IX) with Ar-W in presence of base and solvent will produce the compound (X). [Reaction Scheme 1-5] wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , Ar, and W are as defined elsewhere herein. The reaction is carried out in the presence of a suitable base. As the base, a conventionally known base can widely be used, and examples of the bases include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, and the like; alkali metal hydrides such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, and the like; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylaminopyridine, piperidine, and the like, preferably sodium hydroxide, potassium hydroxide, sodium hydride, potassium hydride, sodium methoxide, sodium ethoxide and potassium tert-butoxide. Any separate one of these bases or a combination of two or more types thereof can be used. The amount of the base to be used is generally 2 to 10 mol, preferably 3 mol, per 1 mol of the compound (IX). The aforementioned reaction is performed in a solvent such as DMF, DMSO, Dioxane, and toluene. No limitations are placed on the solvent as long as the solvent is inactive or substantially inactive with respect to the aforementioned reaction. Examples of such a solvent include alcohol-based solvents such as methanol, ethanol, n-propanol, isopropanol and the like. Any one of these solvents can be used alone or a combination of two or more types thereof can be used generally 1.0 to 20 equivalents, preferably 1.0 to 10 equivalents, per 1 mol of the compound (IX). The reaction temperature varies depending on the starting compound or material, the reaction reagent, the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 0 to 130°C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 5 minutes to 12 hours. Step 1-6: Step 1-6 is a step of preparing the compound (VII) from the compound (X) by the treatment of an acid in a solvent. [Reaction Scheme 1-6] wherein R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , and Ar are as defined elsewhere herein. The aforementioned reaction can be performed under presence of an acid. Among the above, the reaction is performed preferably under the presence of the acid. As the acid, a conventionally known acid can widely be used, and examples of the acid include: trifluoroacetic and hydrochloric acid. Fluorinated alcohols include, without limitation, 2,2,2-trifluoro-ethanol (“TFE”), 1,1,1,3,3,3- hexafluoroisopropanol (“HFIP”), 3,3,4,4,4-pentafluorobutan- 2-ol (“PFB”), and the like. The amount of the acid to be used is generally 1.0 to 5.0 mol, preferably 3.0 to 6.0 mol, per 1 mol of the compound (X). The aforementioned reaction is performed in an substantially inactive with respect to the aforementioned reaction. Examples of the solvent include: fatty acid or alicyclic hydrocarbon-based solvents such as n-hexane, cyclohexane n-heptane, and the like; aromatic hydrocarbon- based solvents such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; ether-based solvents such as diethyl ether, THF, 1,4-dioxane, and the like. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary. The amount of the solvent to be used is generally 1.0 to 20 equivalents, preferably 1.0 to 10 equivalents, per 1 mol of the compound (X). The reaction temperature varies depending on the starting compound or material, the reagent, the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 0 to 50°C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is generally from 5 minutes to 48 hours, preferably from 10 minutes to 12 hours. Step 1-7: Step 1-7 is a step of preparing the compound (V) with the compound (VII) and Compound (VIII) in the presence of a base and solvent. [Reaction Scheme 1-7] Wherein R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 15 , Ar, and Q are as defined elsewhere herein. The aforementioned reaction is performed in an appropriate solvent or without any solvent. When the aforementioned reaction is carried out in the solvent, no limitations are placed on the solvent as long as the solvent is inactive or substantially inactive with respect to the aforementioned reaction. Examples of such a solvent include: fatty acid or alicyclic hydrocarbon-based solvents such as n-hexane, cyclohexane, n-heptane, and the like; aromatic hydrocarbon-based solvents such as benzene, chlorobenzene, toluene, xylene, and the like; halogenated hydrocarbon-based solvents such as methylene chloride, 1,2-dichloroethane, chloroform, and carbon tetrachloride, and the like; ether- based solvents such as diethyl ether, THF, 1,4-dioxane, and the like; ester solvents such as methyl acetate, ethyl acetate, and the like; acetonitrile; preferably methylene chloride, chloroform , and toluene. Any one of these solvents can be used alone or a combination of two or more types thereof can be used when necessary. The amount of the solvent to be used is generally 0.5 to 20 equivalents, preferably 0.5 to 10 equivalents, per 1 mol of the compound represented by formula (VII). A base used for the aforementioned reaction is not particularly limited. As the base, a conventionally known base can widely be used, and examples of the base include: inorganic bases, including alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, and the like; alkali metal hydrides such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides sodium methoxide, sodium ethoxide, potassium tert- butoxide, and the like; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, dimethylamine pyridine, piperidine, and the like; and the like, preferably pyridine. Any separate one of these bases or a combination of two or more types thereof is used. The amount of the base to be used is generally 1.0 to 10.0 mol, preferably 3.0 to 5.0 mol, per 1 mol of the compound (VII). The amount of compound (VII) to be used is generally 1.0 to 3.0 mol, preferably 1.0 to 1.5 mol, per 1 mol of the compound (VIII). The reaction temperature varies depending on the starting compound or material, the reagent, the solvent and the like, but is generally from -20°C to the reflux temperature in the reaction system, preferably from 0 to 130°C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 20 minutes to 12 hours. Step 1-8: Step 1-8 is a step of preparing the compound (I) from the compound (V) and Compound (VI) in the presence of a base. [Reaction Scheme 1-8] wherein R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 15 , Ar, X, Q, m, and n are as defined elsewhere herein. The amount of the compound (VI) to be used is generally 0.5 to 5 mol, preferably 2 to 3 mol, per 1 mol of the compound (V). The aforementioned reaction is performed without any solvent. The aforementioned reaction can be performed under the presence of a base. As the base, a conventionally known base can widely be used, and examples of the base include: inorganic bases, including alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium bicarbonate, sodium bicarbonate, and the like; alkali metal hydroxides such as sodium hydroxide, potassium hydroxide, and the like; alkali metal hydrides such as sodium hydride and potassium hydride, and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, potassium tert-butoxide, and the like; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine, and the like; and the like, preferably pyridine. Any one of these bases or a combination of two or more types thereof is used. In the case of when organic base is used, it can be used in large excess to serve as a solvent. The amount of the base to be used is generally 1.0 to 5.0 mol, preferably 3.0 to 4.0 mol, per 1 mol of the compound (V). The reaction temperature varies depending on the starting compound or material, the reagent, the solvent and the like, but is generally from -40°C to the reflux temperature in the reaction system, preferably from 0 to 135°C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature and the like, but is generally from 10 minutes to 48 hours, preferably from 20 minutes to 24 hours, more preferably from 1 to 12 hours. The compound represented by formula (I) obtained by the method shown in Step 1-8 is easily isolated from a reaction mixture to be purified by use of typical purification means, for example, filtration, solvent extraction, distillation, recrystallization, chromatography, The present mite control agent may necessary contain an additive component (carrier) ordinarily used in agricultural chemical formulations. The additive component can be a carrier (e.g. solid carrier or liquid carrier), a surfactant, a binder or a tackifier, a thickening agent, a coloring agent, a spreader, a sticker, an anti-freeze, a solidification inhibitor, a disintegrator, a decomposition inhibitor, etc. As necessary, other additive components such as antiseptic, vegetable chip and the like can be used. These additive components may be used in one kind or in combination of two or more kinds. The above additive components are explained. The solid carrier can be, for example, mineral carriers such as pyrophyllite clay, kaolin clay, silicastone clay, talc, diatomaceous earth, zeolite, bentonite, acid clay, active clay, Attapulgus clay, vermiculite, perlite, pumice, white carbon (e.g. synthetic silicic acid or synthetic silicate), titanium dioxide and the like; vegetable carriers such as wood flour, corn culm, walnut shell, fruit stone, rice hull, sawdust, wheat bran, soybean flour, powder cellulose, starch, dextrin, saccharide and the like; inorganic salt carriers such as calcium carbonate, ammonium sulfate, sodium sulfate, potassium chloride and the like; and polymer carriers such as polyethylene, polypropylene, polyvinyl chloride, polyvinyl acetate, ethylene-vinyl acetate copolymer, urea-aldehyde resin and the like. The liquid carrier can be, for example, monohydric alcohols such as methanol, ethanol, propanol, isopropanol, butanol, cyclohexanol and the like; polyhydric alcohols such as ethylene glycol, diethylene glycol, propylene glycol, hexylene glycol, polyethylene glycol, polypropylene glycol, glycerine and the like; polyhydric alcohol derivatives such as propylene type glycol ether and the like; ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone, ethers such as ethyl ether, 1,4-dioxane, cellosolve, dipropyl ether, tetrahydrofuran and the like; aliphatic hydrocarbons such as normal paraffin, naphthene, isoparaffin, kerosene, mineral oil and the like; aromatic hydrocarbons such as toluene, C 9-10 alkylbenzene, xylene, solvent naphtha, alkylnaphthalene, high-boiling aromatic hydrocarbon and the like; halogenated hydrocarbons such as 1,2-dichloroethane, chloroform, carbon tetrachloride and the like; esters such as ethyl acetate, diisopropyl phthalate, dibutyl phthalate, dioctyl phthalate, dimethyl adipate and the like; lactones such as γ(gamma)-butyrolactone and the like; amides such as DMF, diethylformamide, dimethylacetamide, N- alkylpyrrolidinone and the like; nitriles such as acetonitrile and the like; sulfur compounds such as dimethyl sulfoxide and the like; vegetable oils such as soybean oil, rapeseed oil, cottonseed oil, coconut oil, castor oil and the like; and water. As for the surfactant, there is no particular restriction. However, the surfactant preferably gels or swells in water. The surfactant can be, for example, non- ionic surfactants such as sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sucrose fatty acid ester, polyoxyethylene fatty acid ester, polyoxyethylene resin acid ester, polyoxyethylene fatty acid diester, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, polyoxyethylene dialkylphenyl ether, polyoxyethylene alkylphenyl ether-formalin condensate, polyoxyethylene polyoxypropylene block polymer, alkyl polyoxyethylene polypropylene block polymer ether, polyoxyethylene alkyl amine, polyoxyethylene fatty acid amide, polyoxyethylene fatty acid bisphenyl ether, polyalkylene benzyl phenyl ether, polyoxyalkylene styryl phenyl ether, acetylene diol, polyoxyalkylene-added acetylene diol, polyoxyethylene ether type silicone, ester type silicone, fluorine-containing surfactant, oil and the like; anionic surfactants such as alkyl sulfate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl phenyl ether sulfate, polyoxyethylene styryl phenyl ether sulfate, alkylbenzenesulfonic acid salt, ligninsulfonic acid salt, alkylsulfosuccinic acid salt, naphthalenesulfonic acid salt, alkylnaphthalenesulfonic acid salt, naphthalenesulfonic acid-formalin condensate salt, alkylnaphthalenesulfonic acid-formalin condensate salt, fatty acid salt, polycarboxylic acid salt, N-methyl-fatty acid sarcosinate, resin acid salt, polyoxyethylene alkyl ether phosphate, polyoxyethylene alkylphenyl ether phosphate and the like; cationic surfactants including alkyl amine salts such as laurylamine hydrochloride, stearylamine hydrochloride, oleylamine hydrochloride, stearylamine acetate, stearylaminopropylamine acetate, alkyl trimethyl ammonium chloride, alkyl dimethyl benzalkonium chloride and the like; and ampholytic surfactants such as betaine type (e.g. dialkyldiaminoethylbetaine or alkyldimethylbenzylbetaine), amino acid type (e.g. dialkylaminoethylglycine or alkyldimethylbenzylglycine) and the like. The binder and tackifier can be, for example, carboxymethyl cellulose or a salt thereof, dextrin, water- soluble starch, xanthan gum, guar gum, sucrose, polyvinylpyrrolidone, gum arabic, polyvinyl alcohol, polyvinyl acetate, sodium polyacrylate, polyethylene glycol having an average molecular weight of 6,000 to 20,000, polyethylene oxide having an average molecular weight of 100,000 to 5,000,000, and natural phospholipid (e.g. cephalinic acid or lecithin). The thickening agent can be, for example, water- soluble polymers such as xanthan gum, guar gum, carboxymethyl cellulose, polyvinylpyrrolidone, carboxyvinyl polymer, acrylic polymer, starch derivative, polysaccharide and the like; and inorganic fine powders such as high-purity The coloring agent can be, for example, inorganic pigments such as iron oxide, titanium oxide, Prussian Blue and the like; and organic dyes such as Alizarine dye, azo dye, metal phthalocyanine dye and the like. The spreader can be, for example, silicone-based surfactant, cellulose powder, dextrin, processed starch, polyaminocarboxylic acid chelate compound, crosslinked polyvinylpyrrolidone, maleic acid and styrene, methacrylic acid copolymer, half ester between polyhydric alcohol polymer and dicarboxylic acid anhydride, and water-soluble salt of polystyrenesulfonic acid. The sticker can be, for example, surfactant (e.g. sodium dialkylsulfosuccinate, polyoxyethylene alkyl ether, polyoxyethylene alkylphenyl ether, or polyoxyethylene fatty acid ester), paraffin, terpene, polyamide resin, polyacrylic acid salt, polyoxyethylene, wax, polyvinyl alkyl ether, alkylphenol-formalin condensate, and synthetic resin emulsion. The anti-freeze can be, for example, polyhydric alcohol (e.g. ethylene glycol, diethylene glycol, propylene glycol, or glycerine). The solidification inhibitor can be, for example, polysaccharide (e.g. starch, alginic acid, mannose or galactose), polyvinylpyrrolidone, white carbon, ester gum and petroleum resin. The disintegrator can be, for example, sodium tripolyphosphate, sodium hexametaphosphate, stearic acid metal salt, cellulose powder, dextrin, methacrylic acid ester copolymer, polyvinylpyrrolidone, polyaminocarboxylic acid chelate compound, sulfonated styrene-isobutylene-maleic anhydride copolymer, and starchpolyacrylonitrile graft copolymer. The decomposition inhibitor can be, for example, desiccants such as zeolite, quick lime, magnesium oxide and the like; antioxidants such as phenol type, amine type, ultraviolet absorbents such as salicylic acid type, benzophenone type and the like. When the present pest control agent contains the above- mentioned additive components, their contents based on mass are selected in a range of ordinarily 5 to 95%, preferably 20 to 90% in the case of carrier (e.g. solid carrier or liquid carrier), ordinarily 0.1 to 30%, preferably 0.5 to 10% in the case of surfactant, and ordinarily 0.1 to 30%, preferably 0.5 to 10% in the case of other additives. The present pest control agent is used in any formulation selected from dust formulation, dust-granule mixture, granule, wettable powder, water-soluble concentrate, water-dispersible granule, tablet, Jumbo, emulsifiable concentrate, oil formulation, solution, flowable concentrate, emulsion, microemulsion, suspoemulsion, ultra-low volume formulation, microcapsule, smoking agent, aerosol, baiting agent, paste, etc. In actual use of the formulation, the formulation can be used per se or after dilution with a diluent (e.g. water) in a given concentration. The application of the formulation containing the present compound or of its dilution product can be conducted by a method ordinarily used, such as dispersion (e.g. spraying, misting, atomizing, powder dispersion, granule dispersion, on-water-surface dispersion, or inbox dispersion), in-soil application (e.g. mixing or drenching), on-surface application (e.g. coating, dust coating or covering), immersion, poison bait, smoking and the like. It is also possible to mix the above-mentioned active ingredient with a livestock feed in order to prevent the infestation and growth of injurious pest, particularly injurious insect in the excreta of livestock. The proportion (mass %, hereinafter also referred to simply as "%") of the active ingredient in the present pest control agent is appropriately selected so as to meet the requirement. The active ingredient is appropriately selected, In dust formulation, dust-granule mixture, etc. 0.01 to 20%, preferably 0.05 to 10% In granule, etc. 0.1 to 30%, preferably 0.5 to 20% In wettable powder, water-dispersible granule, etc. 1 to 70%, preferably 5 to 50% In water-soluble concentrate, solution, etc. 1-95%, preferably 10 to 80% In emulsifiable concentrate, etc. 5 to 90%, preferably 10 to 80% In oil formulation, etc. 1 to 50%, preferably 5 to 30% In flowable concentrate, etc. 5 to 60%, preferably 10 to 50% In emulsion, microemulsion, suspoemulsion, etc. 5 to 70%, preferably 10 to 60% In tablet, bait, paste, etc. 1 to 80%, preferably 5 to 50% In smoking agent, etc. 0.1 to 50%, preferably 1 to 30% In aerosol, etc. 0.05 to 20%, preferably 0.1 to 10% The formulation is sprayed after dilution in an appropriate concentration, or applied directly. When the present pest control agent is used after dilution with a diluent, the concentration of active ingredient is generally 0.1 to 5,000 ppm. When the formulation is used per se, the application amount thereof per unit area is 0.1 to 5,000 g per 1 ha in terms of active ingredient compound; however, the application amount is not restricted thereto. Incidentally, the present pest control agent is sufficiently effective when using the present compound alone as an active ingredient. However, the present pest control with fertilizers and agricultural chemicals such as insecticide, miticide, nematocide, synergist, fungicide, antiviral agent, attractant, herbicide, plant growth- controlling agent and the like. In this case, a higher effect is exhibited. Below are examples of known insecticides, miticides, nematocides and synergist compounds, which may be mixed or used in combination. 1. Acetylcholine esterase inhibitors (1A) carbamates: alanycarb, aldicarb, aldoxycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC (vamidothion), xylylcarb; (1B) Organophosphates: acephate, azamethiphos, azinphosethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifosmethyl, coumaphos, cyanophos, demeton-S-methyl, diamidafos, diazinon, dichlorvos, dicrotophos, dimethoate, dimethylvinphos, dioxabenzofos, disulfoton, DSP (O,O-diethyl O-(4- dimethylsulfamoylphenyl)phosphorothioate), EPN (O-ethyl O-4-nitrophenyl phenylphosphonothioate), ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fenthion, fonofos, fosthiazate, fosthietan, heptenophos, isamidofos, isazophos, isofenphos-methyl, isopropyl O- (methoxyaminothio-phosphoryl)salicylate, isoxathion, malathion, mecarbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxydemeton- methyl, oxydeprofos, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimiphos-methyl, profenofos, propaphos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, tetrachlorvinphos, thiometon, thionazin, triazophos, trichlorfon, vamidothion, dichlofenthion, imicyafos, isocarbophos, mesulfenfos, flupyrazofos. 2. GABA-gated chloride channel blockers (2A) Cyclodiene organochlorines: chlordane, endosulfan, gamma-BHC (benzene hexachloride); (2B) Phenylpyrazoles: acetoprole, ethiprole, fipronil, pyrafluprole, pyriprole, RZI-02-003 (code number). 3. Sodium channel modulators (3A) Pyrethroids/Pyrethrins: acrinathrin, allethrin (includes d-cis-trans and d-trans), bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin (includes beta-), cyhalothrin (includes gamma- and lambda-), cypermethrin (includes alpha-, beta-, theta- and zeta-), cyphenothrin [includes (IR)-trans-isomers], deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin,, halfenprox, imiprothrin, metofluthrin, permethrin, phenothrin [includes (IR)- trans-isomer], prallethrin, profluthrin, pyrethrine, resmethrin, RU15525 (code number), silafluofen, tefluthrin, tetramethrin, tralomethrin, transfluthrin, ZX18901 (code number), fluvalinate (includes tau-), tetramethylfluthrin, meperfluthrin; (3B) DDT/Methoxychlor: DDT (1,1,1-trichloro-2,2-bis(4- chlorophenyl)ethane), methoxychlor. 4. Nicotinic acetylcholine receptor competitive modulators (4A) Neonicotinoids: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam; (4B) Nicotine: nicotine-sulfate. (4C) Sulfoximines: sulfoxaflor (4D) Butenolides: flupyradifurone (4E) Mesoionics: triflumezopyrim, 5. Nicotinic acetylcholine receptor allosteric modulators 6. Glutamate-gated chloride channel allosteric modulators Abamectins, Milbemycins: abamectin, emamectin benzoate, lepimectin, milbemectin, ivermectin, polynactins. 7. Juvenile hormone mimics diofenolan, hydroprene, kinoprene, methothrin, fenoxycarb, pyriproxyfen. 8. Miscellaneous non-specific (multi-site) inhibitors 1,3-dichloropropene, DCIP (bis(2-chloro-1-methylethyl) ether), ethylene dibromide, methyl bromide, chloropicrin, sulfuryl fluoride. 9. Chordotonal organ TRPV channel modulators pymetrozine, flonicamid, pyrifluquinazon. 10. Mite growth inhibitors affecting CHS1 (chitin synthase 1) clofentezine, diflovidazin, hexythiazox, etoxazole. 11. Microbial disruptors of insect midgut membranes BT (Bacillus thuringiensis) agent: Bacillus sphaericus, Bacillus thuringiensis subsp. aizawai, Bacillus thuringiensis subsp. israelensis, Bacillus thuringiensis subsp. kurstaki, Bacillus thuringiensis subsp. tenebrionis, Bt crop proteins (CrylAb, Cry1Ac, CrylFa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34/35Ab1), Bacillus popilliae, Bacillus subtilis. 12. Inhibitors of mitochondrial ATP synthase diafenthiuron, azocyclotin, cyhexatin, fenbutatin oxide, propargite, tetradifon. 13. Uncouplers of oxidative phosphorylation via disruption of the proton gradient chlorfenapyr, DNOC (6-Methyl-2,4-dinitrophenol). 14. Nicotinic acetylcholine receptor channel blockers Nereistoxin analogues: bensultap, cartap, thiocyclam, thiosultap. 15. Inhibitors of chitin biosynthesis affecting CHS1 Benzoylureas: bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, triflumuron, fluazuron. 16. Inhibitors of chitin biosynthesis, type 1 Buprofezin. 17. Molting disruptor, Dipteran Cyromazine. 18. Ecdysone receptor agonists Diacylhydrazines: chromafenozide, halofenozide, methoxyfenozide, tebufenozide. 19. Octopamine receptor agonist Amitraz. 20. Mitochondrial complex III electron transport inhibitors hydramethylnon, acequinocyl, fluacrypyrim, bifenazate, flometoquin. 21. Mitochondrial complex I electron transport inhibitors (METI) METI miticides and insecticides: fenazaquin, fenpyroximate, pyridaben, pyrimidifen, tebufenpyrad, tolfenpyrad Other: rotenone. 22. Sodium channel blockers indoxacarb, metaflumizone. 23. Inhibitors of lipid synthesis Tetronic and Tetramic acid derivatives: spirodiclofen, spiromesifen, spirodiclofen, spirotetramat. 24. Mitochondrial complex IV electron transport inhibitors aluminum phosphide, phosphine, zinc phosphide, calcium cyanide. 25. Mitochondrial complex II electron transport inhibitors cyflumetofen, cyenopyrafen, pyflubumide. 28. Ryanodine receptor modulators chlorantraniliprole, flubendiamide, cyantraniliprole, tetraniliprole. azadirachtin, amidoflumet, benclothiaz, benzoximate, bromopropylate, chinomethionat, CL900167 (code number), cryolite, dicofol, dicyclanil, dienochlor, dinobuton, fenbutatin oxide, fenothiocarb, fluensulfone, flufenerim, flusulfamide, karanjin, metham, methoprene, methoxyfenozide, methyl isothiocyanate, pyridalyl, pyrifluquinazon, sulcofuron-sodium, sulfluramid, sulfoxaflor, flupyradifurone, flometoquin, cyclaniliprole. Entomopathogenic fungi, nematode-pathogenic microorganisms Beauveria bassiana, Beauveria tenella, Verticillium lecanii, Paecilomyces tenuipes, Paecilomyces fumosoroseus, Beauveria brongniartii, Monacrosporium phymatophagum, Pasteuriapenetrans. Sex pheromone (Z)-11-hexadecenal, (Z)-11-hexadecenyl acetate, litlure- A, litlure-B, Z-13-eicosene-10-one, (Z,E)-9,12- tetradecadienyl acetate, (Z)-9-tetradecen-1-ol, (Z)-11- tetradecenyl acetate, (Z)-9,12-tetradecadienyl acetate, (Z,E)-9,11-detradecadienyl acetate. Aconitase inhibitors sodium fluoroacetate. Synergists piperonyl butoxide, DEF (phosphorotrithioic acid S,S,S- tributyl ester). Next, below are examples of the known fungicide or disease damage control agent compounds which may be mixed or used in combination. A. Nucleic acid biosynthesis inhibitor Acylalanines: benalaxyl, benalaxyl-M, furalaxyl, Oxazolidinones: oxadixyl; Butyrolactones: clozylacon, ofurace; Hydroxy-(2-amino)pyrimidines: bupirimate, dimethirimol, ethirimol; Isoxazole: hymexazol; Isothiazolones: octhilinone; Carboxylic acids: oxolinic acid. B. Mitosis and cell division inhibitors Benzimidazoles: benomyl, carbendazim, fuberidazole, thiabendazole; Thiophanates: thiophanate, thiophanate-methyl; N-phenylcarbamates: diethofencarb; Toluamides: zoxamide; Phenylureas: pencycuron; Pyridinylmethylbenzamides: fluopicolide. C. Respiratory inhibitors Pyrimidineamines: diflumetorim; Carboxamides: benodanil, flutolanil, mepronil, fluopyram, fenfuram, carboxin, oxycarboxin, thifluzamide, bixafen, furametpyr, isopyrazam, penflufen, penthiopyrad, sedaxane, boscalid, fluxapyroxad, isofetamid, benzovindiflupyr, inpyrfluxam; Methoxy-acrylates: azoxystrobin, enestroburin, picoxystrobin, pyraoxystrobin, coumoxystrobin, enoxastrobin, flufenoxystrobin; Methoxy-carbamates: pyraclostrobin, pyrametostrobin, triclopyricarb; Oxyimino acetates: kresoxim-methyl, trifloxystrobin; Oxyimino-acetamides: dimoxystrobin, metominostrobin, orysastrobin, fenaminstrobin; Oxazolidine-diones: famoxadone; Dihydro-dioxazines: fluoxastrobin; Imidazolinones: fenamidone; Benzyl-carbamates: pyribencarb; Cyano-imidazoles: cyazofamid; Dinitrophenyl crotonates: binapacryl, meptyldinocap, dinocap; 2,6-Dinitro-anilines: fluazinam; Pyrimidinone hydrazones: ferimzone; Triphenyl tin: TPTA, TPTC, TPTH; Thiophene-carboxamides: silthiofam Triazolo-pyrimidylamines: ametoctradin. D. Amino acid and protein synthesis inhibitors Anilino-pyrimidines: cyprodinil, mepanipyrim, pyrimethanil; Enopyranuronic acid: blasticidin-S, mildiomycin; Hexopyranosyl antibiotic: kasugamycin; Glucopyranosyl antibiotic: streptomycin; Tetracycline antibiotic: oxytetracycline. E. Signal transduction inhibitors Quinoline: quinoxyfen; Quinazolines: proquinazid; Phenylpyrroles: fenpiclonil, fludioxonil; Dicarboxyimides: chlozolinate, iprodione, procymidone, vinclozolin. F. Lipid synthesis and membrane integrity inhibitors Phosphoro-thiolates: edifenphos, iprobenfos, pyrazophos; Dithiolanes: isoprothiolane; Aromatic hydrocarbons: biphenyl, chloroneb, dicloran, quintozene, tecnazene, tolclofos-methyl; 1,2,4-Thiadiazoles: etridiazole; Carbamates: iodocarb, propamocarb-hydrochloride, prothiocarb; Cinnamic acid amides: dimethomorph, flumorph; Valineamide carbamates: benthiavalicarb-isopropyl, iprovalicarb, valifenalate; Mandelic acid amides: mandipropamid; Bacillus subtilis and the fungicidal lipopeptides produced: Bacillus subtilis (strain: QST 713). G. Inhibitors of sterol biosynthesis in membranes Pyridines: pyrifenox; Pyrimidines: fenarimol, nuarimol; Imidazoles: imazalil, oxpoconazole-fumarate, pefurazoate, prochloraz, triflumizole; Triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, etaconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, furconazole, furconazole-cis, quinconazole, mefentrifluconazole ; Morpholines: aldimorph, dodemorph, fenpropimorph, tridemorph; Piperidines: fenpropidin, piperalin; Spiroketal amines: spiroxamine; Hydroxyanilides: fenhexamid; Thiocarbamates: pyributicarb; Allylamines: naftifine, terbinafine. H. Glucan synthesis inhibitors Glucopyranosyl type antibiotic: validamycin; Peptidylpyridine nucleotide compound: polyoxin. I. Melanine synthesis inhibitors Isobenzo-furanones: phthalide; Pyrrolo-quinolines: pyroquilon; Triazolobenzo-thiazoles: tricyclazole; Carboxamides: carpropamid, diclocymet; Propionamides: fenoxanil. P. Host plant defence inducers Benzothiadiazoles: acibenzolar-S-methyl; Benzoisothiazoles: probenazole; Thiadiazole-carboxamides: tiadinil, isotianil Natural product: laminarin. Copper compound: copper hydroxide, copper dioctanoate, copper oxychloride, copper sulfate, cuprous oxide, oxine- copper, Bordeaux mixture, copper nonyl phenol sulphonate; Sulfur compound: sulfur; Dithiocarbamates: ferbam, mancozeb, maneb, metiram, propineb, thiram, zineb, ziram, cufraneb; Phthalimides: captan, folpet, captafol; Chloronitriles: chlorothalonil; Sulfamides: dichlofluanid, tolylfluanid; Guanidines: guazatine, iminoctadine-albesilate, iminoctadine-triacetate, dodine; Other compounds: anilazine, dithianon, cymoxanil, fosetyl (aluminum, calcium, sodium), phosphorus acid and salts, tecloftalam, triazoxide, flusulfamide, diclomezine, methasulfocarb, ethaboxam, cyflufenamid, metrafenone, potassium bicarbonate, sodium bicarbonate, BAF-045 (code number) (5,7-dimethoxy-2-(2,4,6-trichlorophenyl)- [1,2,4]triazolo[1,5-a]pyrimidine), BAG-010 (code number), benthiazole, bronopol, carvone, chinomethionat, dazomet, DBEDC, debacarb, dichlorophen, difenzoquat-methyl sulfate, dimethyl disulfide, diphenylamine, ethoxyquin, flumetover, fluoroimide, flutianil, furancarboxylic acid, metam, nabam, natamycin, nitrapyrin, nitrothal-isopropyl, o- phenylphenol, oxazinylazole, oxyquinoline sulfate, phenazine oxide, polycarbamate, pyriofenone, fenpyrazamine, silver, pyrisoxazole, tebufloquin, tolnifanide, trichlamide, mineral oils, organic oils, tolprocarb, oxathiapiprolin. Below are examples of the known herbicidal compounds and plant growth regulators which may be mixed or used in combination. A1. Acetyl CoA carboxylase (ACCase) inhibitors (A1-1) Aryloxyphenoxy propionates: clodinafop-propargyl, cyhalofop-butyl, diclofop-methyl, diclofop-P-methyl, haloxyfop, haloxyfop-etotyl, haloxyfop-P, metamifop, propaquizafop, quizalofop-ethyl, quizalofop-P-ethyl, quizalofop-P-tefuryl, fenthiaprop-ethyl; (A1-2) Cyclohexanediones: alloxydim, butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim; (A1-3) Phenylpyrazolines: aminopyralid, pinoxaden; B. Acetolactate synthase (ALS) inhibitors (B-1) Imidazolinones: imazamethabenz-methyl, imazamox, imazapic (includes salts with amine, etc.), imazapyr (includes salts with isopropylamine, etc.), imazaquin, imazethapyr; (B-2) Pyrimidinyloxy benzoate: bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrithiobac-sodium, pyrimisulfan, triafamone; (B-3) Sulfonylaminocarbonyl-triazolinones: flucarbazone- sodium, thiencarbazone (includes sodium salt, methyl ester, etc.), propoxycarbazone-sodium, procarbazone- sodium, iofensulfuron-sodium; (B-4) Sulfonylureas: amidosulfuron, azimsulfuron, bensulfuron-methyl, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flupyrsulfuron-methyl- sodium, foramsulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron-methyl-sodium, mesosulfuron- methyl, thifensulfuron-methyl, triasulfuron, tribenuron- methyl, trifloxysulfuron-sodium, triflusulfuron-methyl, tritosulfuron, orthosulfamuron, propyrisulfuron, metazosulfuron, flucetosulfuron; (B-5) Triazolopyrimidines: cloransulam-methyl, diclosulam, florasulam, flumetsulam, metosulam, penoxsulam, pyroxsulam; C1. Photosynthesis at photosystem II inhibitors (1) (C1-1) Phenylcarbamates: desmedipham, phenmedipham; (C1-2) Pyridazinones: chloridazon, brompyrazon; (C1-3) Triazines: ametryn, atrazine, cyanazine, desmetryne, dimethametryn, eglinazine-ethyl, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazine, terbutryn, trietazine; (C1-4) Triazinones: metamitron, metribuzin; (C1-5) Triazolinones: amicarbazone; (C1-6) Uracils: bromacil, lenacil, terbacil; C2. Photosynthesis at photosystem II inhibitors (2) (C2-1) Amides: pentanochlor, propanil; (C2-2) Ureas: chlorbromuron, chlorotoluron, chloroxuron, dimefuron, diuron, ethidimuron, fenuron, fluometuron, isoproturon, isouron, linuron, methabenzthiazuron, metobromuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron, metobenzuron; C3. Photosynthesis at photosystem II inhibitors (3) (C3-1) Benzothiadiazones: bentazone; (C3-2) Nitriles: bromofenoxim, bromoxynil (includes esters of butyric acid, octanoic acid, heptanoic acid, etc.), ioxynil; (C3-3) Phenylpyrazines: pyridafol, pyridate; D. Photosystem-I-electron acceptors (D-1) Bipyridyliums: diquat, paraquat dichloride; E. Protoporphyrinogen oxidase (PPO) inhibitors (E-1) Diphenylethers: acifluorfen-sodium, bifenox, chlomethoxyfen, ethoxyfen-ethyl, fluoroglycofen-ethyl, fomesafen, lactofen, oxyfluorfen; (E-2) N-phenylphthalimides: cinidon-ethyl, flumiclorac- pentyl, flumioxazin, chlorphthalim; (E-3) Oxadiazoles: oxadiargyl, oxadiazon; (E-4) Oxazolidinediones: pentoxazone; (E-5) Phenylpyrazoles: fluazolate, pyraflufen-ethyl; (E-6) Pyrimidinediones: benzfendizone, butafenacil, saflufenacil, tiafenacil; (E-7) Thiadiazoles: fluthiacet-methyl, thidiazimin; (E-8) Triazolinones: azafenidin, carfentrazone-ethyl, (E-9) Other compounds: flufenpyr-ethyl, profluazol, pyraclonil, SYP-298 (code number), SYP-300 (code number); F1. Inhibitors of carotenoid biosynthesis at the phytoene desaturase step (PDS) (F1-1) Pyridazinones: norflurazon; (F1-2) Pyrimidinecarboxamides: diflufenican, picolinafen; (F1-3) Other compounds: beflubutamid, fluridone, flurochloridone, flurtamone; F2. 4-Hydroxyphenyl-pyruvate-dioxygenase (HPPD) inhibitors (F2-1) Callistemones: mesotrione; (F2-2) Isoxazoles: pyrasulfotole, isoxaflutole, isoxachlortole; (F2-3) Pyrazoles: benzofenap, pyrazolynate, pyrazoxyfen, topramezone; (F2-4) Triketones: sulcotrione, tefuryltrione, tembotrione, pyrasulfotole, topramezone, bicyclopyrone; F3. Carotenoid biosynthesis inhibitors (unknown target) (F3-1) Diphenyl ethers: aclonifen; (F3-2) Isoxazolidinones: clomazone; (F3-3) Triazoles: amitrole; G. EPSP synthase inhibitors (aromatic amino acid biosynthesis inhibitors) (G-1) Glycines: glyphosate (includes salts of sodium, amine, propylamine, isopropylamine, dimethylamine, trimesium, etc.); H. Glutamine synthetase inhibitors (H-1) Phosphinic acids: bilanafos, glufosinate (includes salts of amine, sodium, etc.); I. Dihydropteroate (DHP) synthetase inhibitors (I-1) Carbamates: asulam; K1. Microtubule assembly inhibitors (K1-1) Benzamides: propyzamide, tebutam; (K1-2) Benzoic acids: chlorthal-dimethyl; (K1-3) Dinitroanilines: benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine, trifluralin; (K1-4) Phosphoramidates: amiprofos-methyl, butamifos; (K1-5) Pyridines: dithiopyr, thiazopyr; K2. Inhibitors of mitosis/microtubule organization (K2-1) Carbamates: carbetamide, chlorpropham, propham, swep, karbutilate; K3. Very-long-chain fatty acids (VLCFAs) inhibitors (cell division inhibitors) (K3-1) Acetamides: diphenamid, napropamide, naproanilide; (K3-2) Chloroacetamides: acetochlor, alachlor, butachlor, butenachlor, diethatyl-ethyl, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, pethoxamid, pretilachlor, propachlor, propisochlor, S-metolachlor, thenylchlor; (K3-3) Oxyacetamides: flufenacet, mefenacet; (K3-4) Tetrazolinones: fentrazamide; (K3-5) Other compounds: anilofos, bromobutide, cafenstrole, indanofan, piperophos, fenoxasulfone, pyroxasulfone, ipfencarbazone; L. Cellulose synthesis inhibitors (L-1) Benzamides: isoxaben; (L-2) Nitriles: dichlobenil, chlorthiamid; (L-3) Triazolocarboxamides: flupoxame; M. Uncouplers (Membrane disruptors) (M-1) Dinitrophenols: dinoterb, DNOC (includes salts of amine, sodium, etc.); N. Lipid biosynthesis inhibitors (excluding ACCase inhibitors) (N-1) Benzofurans: benfuresate, ethofumesate; (N-2) Halogenated carboxylic acids: dalapon, flupropanate, TCA (trichloroacetic acid) (includes salts of sodium, calcium, ammonia, etc.); (N-3) Phosphorodithioates: bensulide; (N-4) Thiocarbamates: butylate, cycloate, dimepiperate, EPTC, esprocarb, molinate, orbencarb, pebulate, prosulfocarb, thiobencarb, tiocarbazil, tri-allate, vernolate; O. Synthetic auxins (O-1) Benzoic acids: chloramben, 2,3,6-TBA (2,3,6- trichlorobenzoic acid), dicamba (includes salts of amine, diethylamine, isopropylamine, diglycolamine, sodium, lithium, etc.); (O-2) Phenoxycarboxylic acids: 2,4,5-T, 2,4-D (includes salts of amine, diethylamine, triethanolamine, isopropylamine, sodium, lithium, etc.), 2,4-DB (4-(2,4- dichlorophenoxy)butyric acid), clomeprop, dichlorprop, dichlorprop-P, MCPA ((4-chloro-2-methylphenoxy)acetic acid), MCPA-thioethyl, MCPB (4-(4-chloro-2- methylphenoxy)butyric acid) (includes sodium salt, ethylester, etc.), mecoprop (includes salts of sodium, potassium, isopropylamine, triethanolamine, dimethylamine, etc.), mecoprop-P; (O-3) Pyridine carboxylic acids: clopyralid, fluroxypyr, picloram, triclopyr, triclopyr-butotyl, halauxifen- methyl; (O-4) Quinoline carboxylic acids: quinclorac, quinmerac; (O-5) Other compound: benazolin; P. Auxin transport inhibitors (P-1) Phthalamates: naptalam (includes sodium salts, etc.); (P-2) Semicarbazones: diflufenzopyr; Z. Compounds with unknown mode of action flamprop-M (includes methyl, ethyl and isopropyl esters), flamprop (includes methyl, ethyl and isopropyl esters), chlorflurenol-methyl, cinmethylin, cumyluron, daimuron, methyl dymron, difenzoquat, etobenzanid, fosamine, pyributicarb, oxaziclomefone, acrolein, AE-F-150954 (code number), aminocyclopyrachlor, cyanamide, quinoclamine, endothal-disodium, phenisopham, SL-573 (code number) (1-cyclopropylmethyl-6-methoxy-4-phenyl- 2(1H)-quinazolinone), cyclopyrimorate Plant growth- controlling agent: 1-methylcyclopropene, 1- naphthylacetamide, 2,6-diisopropylnaphthalene, 4-CPA ((4-chlorophenoxy)acetic acid), benzylaminopurine, ancymidol, aviglycine, carvone, chlormequat, cloprop, cloxyfonac, cloxyfonac-potassium, cyclanilide, cytokinins, daminozide, dikegulac, dimethipin, ethephon, ethychlozate, flumetralin, flurenol, flurprimidol, forchlorfenuron, gibberellin acid, inabenfide, indole acetic acid, indole butyric acid, maleic hydrazide, mefluidide, mepiquat chloride, n-decanol, paclobutrazol, prohexadione-calcium, prohydrojasmon, sintofen, thidiazuron, triacontanol, trinexapac-ethyl, uniconazole, uniconazole-P, 4-oxo-4-(2-phenylethyl)aminobutyric acid (chemical name, CAS registration No.: 1083-55-2). Next, below are examples of the known safeners which may be mixed or used in combination. Benoxacor, furilazole, dichlormid, dicyclonone, DKA-24 (N1,N2-diallyl-N2-dichloroacetylglycineamide), AD-67 (4- dichloroacetyl-1-oxa-4-azaspiro[4.5]decane), PPG-1292 (2,2- dichloro-N-(1,3-dioxan-2-ylmethyl)-N-(2-propenyl)acetamide), R-29148 (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine), cloquintocet-methyl, 1,8-Naphthalic anhydride, mefenpyrdiethyl, mefenpyr, mefenpyr-ethyl, fenchlorazole O ethyl, fenclorim, MG-191 (2-dichloromethyl-2-methyl-1,3- dioxane), cyometrinil, flurazole, fluxofenim, isoxadifen, isoxadifen-ethyl, mecoprop, MCPA, daimuron, 2,4-D ((2,4- dichlorophenoxy)acetic acid), MON 4660 (code number) (4- (dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane), oxabetrinil, cyprosulfamide, lower alkyl-substituted benzoic acid, TI-35 (code number) and N-(2-methoxybenzoyl)-4- [(methylaminocarbonyl)amino]benzenesulfonamide(chemical The pest control agent of the present disclosure constituted as above exhibits an excellent control effect to pest of Orthoptera, Thysanoptera, Hemiptera, Coleoptera, Diptera, Lepidoptera, Hymenoptera, Collembola, Thysanura, Blattodea, Isoptera, Psocoptera, Mallophaga, Anoplura, plant-feeding mites, plant parasitic nematodes, plant parasitic mollusc pests, other crop pests, nuisance pests, sanitary insects, parasites, etc. The following species are examples of such pests. Orthopteran pest can be, for example, Tettigoniidae: Ruspolia lineosa, etc., Gryllidae: Teleogryllus emma, etc., Gryllotalpidae: Gryllotalpa orientalis, Acrididae: Oxya hyla intricate, Locusta migratoria, Melanoplus sanguinipes, etc., Pyrgomorphidae: Atractomorpha lata, Eneopteridae: Euscrytus japonicus, Tridactylidae: Xya japonicus, etc. Thysanopteran pests can be, for example, Thripidae: Frankliniella intonsa, Frankliniella occidentalis, Scirtothrips dorsalis, Thrips palmi, Thrips tabaci, etc., Phlaeothripidaes: Ponticulothrips diospyrosi, Haplothrips aculeatus, etc. Hemipteran pests can be, for example, Cicadidae: Mogannia minuta, etc., Aphrophoridae: Aphorphora intermedia, etc., Membracicdae: Machaerotypus sibiricus, etc., Cicadellidae: Arboridia apicalis, Empoasca onukii, Nephotettix cincticeps, Recilia dorsalis, etc., Cixiidae: Pentastiridius apicalis, etc., Delphacidae: Laodelphax striatella, Nilaparvata lugens, Meenoplidae: Nisia nervosa, etc., Derbidae: Kamendaka saccharivora, etc., Cixidia okunii: Achilus flammeus, etc., Ricaniidae: Orosanga japonicus, etc., Flatidae: Mimophantia maritima, etc., Psyllidae: Cacopsylla pyrisuga, etc., Calophyidae: Calophya mangiferae, etc., Phylloxeridae: Daktulosphaira vitifoliae, etc., Adelgidae: Adelges laricis, Adelges tsugae, etc., Aphydidae: Acyrthosiphon pisum, Aphis gossypii, Aphis spiraecola, Lipaphis erysimi, Myzus persicae, Schizaphis graminum, Rhopalosiphum padi, etc., Aleyrodidae: Aleurocanthus spiniferus, Bemisia tabaci, Bemisia argentifolii, Trialeurodes vaporariorum, etc., Margarodidae: Drosicha corpulenta, Icerya purchasi, etc., Pseudococcidae: Dysmicoccus brevipes, Planococcus citri, Pseudococcus comstocki, etc., Coccidae: Ceroplastes ceriferus, etc., Aclerdidae: Aclerda takahasii, etc., Diaspididae: Aonidella aurantii, Diaspidiotus perniciosus, Unaspis yanonensis, etc., Miridae: Lygus hesperus, Trigonotylus caelestialium, etc., Tingidae: Stephanitis pyrioides, Stephanitis nashi, etc., Pentatomidae: Eysarcoris aeneus, Lagynotomus elongatus, Nezara viridula, Plautia crossota, etc., Plataspidae: Megacopta cribaria, etc., Lygaeidae: Cavelerius saccharivorus, etc., Malcidae: Malcus japonicus, etc., Pyrrhocoridae: Dysdercus cingulatus, etc., Alydidae: Leptocorisa acuta, Leptocorisa chinensis, etc., Coreidae: Anacanthocoris striicornis, etc., Rhopalidae: Rhopalus maculatus, etc., Cimicidae: Cimex lectularis, etc. Coleoptera pests can be, for example, Scarabaeidae: Anomala cuprea, Anomala rufocuprea, Popillia japonica, Oryctes rhinoceros, etc., Elateridae: Agriotes ogurae, Melanotus okinawensis, Melanotus fortnumi, etc., Dermestidae: Anthrenus verbasci, etc., Bostrychidae: Heterobostrychus hamatipennis, etc., Anobiidae: Stegobium paniceum, etc., Ptinidae: Pitinus clavipes, etc., Trogossitidae: Tenebroides manritanicus, etc., Cleridae: Necrobia rufipes, Nitidulidae: Carpophilus hemipterus, etc., Silvanidae: Ahasverus advena, etc., Laemophloeidae: Cryptolestes ferrugineus, etc., Coccinellidae: Epilachna varivestis, Henosepilachna vigintioctopunctata, etc., Tenebrionidae: Tenebrio molitor, Tribolium castaneum, etc., Meloidae: Epicauta gorhami, etc., Cerambycidae: Anoplophora glabripennis, Xylotrechus pyrrhoderus, Monochamus alternatus, etc., Bruchidae: Callosobruchus chinensis, etc., Chrysomelidae: Leptinotarsa decemlineata, Diabrotica virgifera, Phaedon brassicae, Phyllotreta striolata, etc., Brentidae: Cylas formicarius, etc., Curculionidae: Hypera postica, Listroderes costirostris, Euscepes postfasciatus, etc., Erirhinidae: Echinocnemus bipunctatus, Lissorhoptrus oryzophilus, etc., Dryophthoridae: Sitophilus zeamais, Sphenophrus venatus, etc., Scolytidae: Tomicus piniperda, etc., Platypodidae: Crossotarsus niponicus, etc., Lyctidae: Lyctus brunneus, etc. Diptera pests can be, for example, Tipulidae: Tipila aino, etc., Mycetophidae: Exechia shiitakevora, etc., Sciaridae: Pnyxia scabiei, etc., Cecidomyiidae: Asphondylia yushimai, Mayetiola destructor, etc., Culicidae: Aedes aegypti, Culex pipiens pallens, etc., Simuliidae: Simulim takahasii, etc., Chironomidae: Chironomus oryzae, etc., Tabanidae: Chrysops suavis, Tabanus trigonus, etc., Syrphidae: Eumerus strigatus, etc., Tephritidae: Bactrocera dorsalis, Euphranta japonia, Ceratitis capitata, etc., Agromyzidae: Liriomyza trifolii, Chromatomyia horticola, etc., Chloropidae: Meromyza nigriventris, etc., Drosophilidae: Drosophila suzukii, Drosophila melanogaster, etc., Ephydridae: Hydrellia griseola, etc., Hippoboscidae: Hippobosca equina, etc., Scatophagidae: Parallelpmma sasakawae, etc., Anthomyiidae: Delia antiqua, Delia platura, etc., Fanniidae: Fannia canicularis, etc., Muscidae: Musca domestica, Stomoxys calcitrans, etc., Sarcophagidae: Sarcophaga peregrina, etc., Gasterophilidae: Gasterophilus intestinalis, etc., Hypodermatidae: Hypoderma lineatum, etc., Oestridae: Oestrus ovis, etc. Lepidoptera pests can be, for example, Hepialidae: Endoclita excrescens, etc., Heliozelidae: Antispila ampelopsia, etc., Cossidae: Zeuzera leuconotum, etc., Tortricidae: Archips fuscocupreanus, Adoxophyes orana fasciata, Grapholita molesta, Homona magnanima, Leguminivora glycinivorella, Cydia pomonella, etc., Cochylidae: Eupoecilia ambiguella, etc., Tineidae: Nemapogon granella, Tinea translucens, etc., Bucculatricidae: Bucculatrix pyrivorella, etc., Lyonetiidae: Lyonetia clerkella, etc., Gracilariidae: Caloptilia theivora, Phyllonorycter ringoniella, etc., Phyllocnistidae: Phyllocnistis citrella, etc., Acrolepiidae: Acrolepiopsis sapporensis, etc., Yponomeutidae: Plutella xylostella, Yponomeuta orientalis, etc., Argyresthidae: Argyresthia conjugella, etc., Sesidae: Nokona regalis, etc., Gelechiidae: Phthorimaea operculella, Sitotroga cerealella, Pectinophora gossypiella, etc., Carposinidae: Carposina sasakii, etc., Zygaenidae: Illiberis pruni, etc., Limacodidae: Monema flavescens, etc., Crambidae: Ancylolomia japonica, Chilo suppressalis, Cnaphalocrosis medinalis, Ostrinia furnacalis, Ostrinia nubilalis, etc., Pyralidae: Cadra cautella, Galleria mellonella, etc., Pterophoridae: Nippoptilia vitis, etc., Papilionidae: Papilio xuthus, etc., Pieridae: Pieris rapae, etc., Hesperiidae: Parnara guttata guttata, etc., Geometridae: Ascotis selenaria, etc., Lasiocampidae: Dendrolimus spectabilis, Malacosomaneustrium testaceum, etc., Sphingidae: Agrius convolvuli, etc., Lymantriidae: Arna pseudoconspersa, Lymantria dispar, etc., Arctiidae: Hyphantria cunea, etc., Noctuidae: Agrotis ipsilon, Autographa nigrisigna, Helicoverpa armigera, Helicoverpa zea, Heliothis virescens, Spodoptera exigua, Spodoptera litura, etc. Hymenoptera pests can be, for example, Tenthredinidae: Apethymus kuri, Athalia rosae ruficornis, etc., Cynipidae: Dryocosmus kuriphilus, etc., Vespidae: Vespa simillima xanthoptera, etc., Formicidae: Solenopsis invicta, etc., Megachilidae: Megachile nipponica, etc. Order Collembola pests can be, for example, Sminthuridae: Bourletiella hortensis, etc. Order Thysanura pests can be, for example, Lepismatidae: Lepisma saccharina, Ctenolepisma villosa, etc. Blattodea pests can be, for example, Blattidae: Periplaneta americana, Blattellidae: Blattella germanica, etc. Order Isoptera pests can be, for example, Kalotermitidae: Incisitermes minor, etc., Rhinotermitidae: Coptotermes formosanus, etc., Termitidae: Odontotermes formosanus, etc. Order Psocoptera pests can be, for example Trogiidae: Trogium pulsatorium, etc., Liposcelididae: Liposcelis corrodens, etc. Order Mallophaga pests can be, for example, Menoponidae: Lipeurus caponis, etc., Trichodectidae: Damalinia bovis, etc. Order Anoplura pests can be, for example, Haematopinidae: Haematopinus suis, etc., Pediculine: Pediculus humanus, etc., Linognathidae: Linognathus setosus, etc., Pthiridae: Phthrius pubis, etc. Plant-feeding mites can be, for example, Eupodidae: Penthaleus major, etc., Tarsonemidae: Phytonemus pallidus, Polyphagotarsonemus latus, etc., Pyemotidae: Siteroptes sp., etc., Tenuipalpidae: Brevipalpus lewisi, etc., Tuckerellidae: Tuckerella pavoniformis, etc., Tetranychidae: Eotetranychus boreus, Panonychus citri, Panonychus ulmi, Tetranychus urticae, Tetranychus kanzawai, etc., Nalepellidae: Trisetacus pini, etc., Eriophyidae: Aculops pelekassi, Epitrimerus pyri, Phyllocoptruta oleivola, etc., Diptilomiopidae: Diptacus crenatae, etc., Acaridae: Aleuroglyphus ovatus, Tyrophagus putrescentiae, Rhizoglyphus robini, etc. Plant-parasitic nematodes can be, for example, Longidoridae: Xiphinema index, etc., Trichodoridae: Paratrichodorus minor, etc., Rhabditidae: Rhabditella sp., etc., Tylenchidae: Aglenchussp., etc., Tylodoridae: Cephalenchus sp., etc., Anguinidae: Nothotylenchus acris, Ditylenchus destructor, etc., Hoplolaimidae: Rotylenchulus reniformis, Helicotylenchus dihystera, etc., Paratylenchidae: Paratylenchus curvitatus, etc., Meloidogynidae: Meloidogyne incognita, Meloidogyne hapla, etc., Heteroderidae: Globodera rostochiensis, Heterodera glycines, etc., Telotylenchidae: Tylenchorhynchus claytoni etc., Psilenchidae: Psilenchus sp., etc., Criconematidae: Criconemoides sp., etc., Spaeronematidae: Sphaeronema camelliae, etc., Pratylenchidae: Sphaeronema camelliae, Radopholus citrophilus, Radopholus similis, Nacobbus aberrans, Pratylenchus penetrans, Pratylenchus coffeae, etc., Iotonchiidae: Iotonchium ungulatum, etc., Aphelenchidae: Aphelenchus avenae, etc., Aphelenchoididae: Aphelenchoides besseyi, Aphelenchoides fragariae, etc., Palasitaphelenchidae: Bursaphelenchus xylophilus, etc. Plant-parasitic mollusc pests can be, for example, Pilidae: Pomacea canaliculata, etc., Veronicellidae: Leavicaulis alte, etc., Achatinidae: Achatina fulica, etc., Philomycidae: Meghimatium bilineatum, etc., Succineidae: Succinea lauta, etc., Didcidae: Discus pauper, etc., Zonitidae: Zonitoides yessoensis, etc., Limacidae: Limax flavus, Deroceras reticulatum, etc., Helicarionidae: Parakaliella harimensis, etc., Bradybaenidae: Acusta despecta sieboldiana, Bradybaena similaris, etc. Other pests such as injurious animals, uncomfortable animals, sanitary insects, livestock insects, parasites, and the like can be, for example, Acari Macronysshidae: Ornithonyssus sylvialum, etc., Varroidae: Varroa jacobsoni, etc., Dermanyssidae: Dermanyssus gallinae, etc., Macronyssidae: Ornithonyssus sylvialum, etc., Ixodidae: Boophilus microplus, Rhipicephalus sanguineus, Haemaphysalis longicornis, etc., Sacroptidae: Sarcoptes scabiei, etc., Isopoda Armadillididae: Armadillidium vulgare, etc., Decapoda Astacidae: Procambarus clarkii, etc., Chilopoda pests: Scutigeromorpha Sutigeridae, Thereuonema tuberculata, Scolopendromorpha Scolopendra subpinipes, etc. Diplopoda pests: Polydesmida Paradoxosomatidae Oxidus gracillis, etc. Araneae Latrodectus hasseltii: Theridiiadae hasseltii, etc., Clubionidae: Chiracanthium japonicum, etc., Order Scorpionida: Androctonus crassicauda, etc., Parasitic roundworm: Ascaris lumbricoides, Syphacia sp., Wucherebia bancrofti, etc., Parasitic flatworm: Distomum sp., Paragonimus westermanii, Metagonimus yokokawai, Schistosoma japonicum, Taenia solium, Taeniarhynchus saginatus, Echinococcus sp., Diphyllobothrium latum, etc. The pest control agent of the present disclosure also exhibits control effect to the above-mentioned pests, etc., which already have resistance to existing pest control agents. Further, the control agent of the present disclosure can be applied to plants which already have resistance to insects, diseases, herbicides, etc., owing to genetic modification and artificial mating, etc. Formulations The present disclosure also relates to an agrochemical composition comprising an auxiliary or an excipient and at least one compound of the present disclosure or a mixture thereof. An agrochemical composition comprises a pesticidally effective amount of a compound of the present disclosure or a mixture thereof. The term "pesticidally effective amount" is defined below. The compound of the present invention or the mixtures thereof can be converted into customary types of agrochemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further compositions types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Mono-graph No. 2, 6th Ed. May 2008, CropLife International. The composition of the present disclosure is prepared in a known manner, such as described by Mollet and Grubenmann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005. Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders. Suitable solvents and liquid carriers are water and organic solvents. Suitable solid carriers or fillers are mineral earths. Suitable surfactants are surface-active compounds, e.g. anionic, cationic, nonionic, and amphoteric surfactants, block polymers, polyelectrolytes. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. & Detergents, McCutcheon’s Directories, Glen Rock, USA, 2008 (International or North American Ed.). Suitable anionic surfactants are alkali, alkaline earth, or ammonium salts of sulfonates, sulfates, phosphates, carboxylates. Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar- based surfactants, polymeric surfactants. Suitable cationic surfactants are quaternary surfactants. The agrochemical composition of the present disclosure generally comprises between 0.01 and 95%, preferably between 0.1 and 90%, and most preferably between 0.5 and 75%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100%. Various types of oils, wetters, adjuvants, or fertilizer may be added to the active substances or the compositions comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1. The user applies the composition according to the present disclosure usually from a predosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, of the ready- to-use spray liquor are applied per hectare of agricultural useful area. The compound of the present disclosure is suitable for use in protecting crops, plants, plant propagation materials, e.g. seeds, or soil or water, in which pests. Therefore, the invention also relates to a plant protection method, which comprises contacting crops, plants, plant propagation materials, e.g. seeds, or soil or water, in which the plants are growing, to be protected from attack or infestation by animal pests, with a pesticidally effective amount of a compound of the present disclosure. The compound of the present disclosure is also suitable for use in combating or controlling animal pests. Therefore, the present disclosure also relates to a method of combating or controlling animal pests, which comprises contacting the animal pests, their habitat, breeding ground, or food supply, or the crops, plants, plant propagation materials, e.g. seeds, or soil, or the area, material or environment in which the animal pests are growing or may grow, with a pesticidally effective amount of a compound of the present disclosure. The compound of the present disclosure is effective through both contact and ingestion to any and all developmental stages, such as egg, larva, pupa, and adult. The compound of the present disclosure can be applied as such or in form of compositions comprising them. The application can be carried out both before and after the infestation of the crops, plants, plant propagation materials by the pests. The term "contacting" includes both direct contact (applying the compound/composition of the present disclosure directly on the animal pest or plant) and indirect contact (applying the compound/composition of the present disclosure to the locus). The term “animal pest” includes arthropods, gastropods, and are arthropods, preferably insects and arachnids, in particular insects. Animal pests are also described elsewhere herein. As used herein, the term “animal” includes warm-blooded animals (including humans) and fish. Preferred are mammals, such as cattle, sheep, swine, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, water buffalo, donkeys, fallow deer and reindeer, and also in furbearing animals such as mink, chinchilla and raccoon, birds such as hens, geese, turkeys and ducks and fish such as fresh- and salt-water fish such as trout, carp and eels. Particularly preferred are domestic animals, such as dogs or cats. The term “plant” includes cereals, e.g. durum and other wheat, rye, barley, triticale, oats, rice, or maize (fodder maize and sugar maize / sweet and field corn); beet, e.g. sugar beet, or fodder beet; fruits, e.g. pomes, stone fruits, or soft fruits, e.g. apples, pears, plums, peaches, nectarines, almonds, cherries, papayas, strawberries, raspberries, blackberries or gooseberries; leguminous plants, e.g. beans, lentils, peas, alfalfa, or soybeans; oil plants, e.g. rapeseed (oilseed rape), turnip rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts, or soybeans; cucurbits, e.g. squashes, pumpkins, cucumber or melons; fiber plants, e.g. cotton, flax, hemp, or jute; citrus fruit, e.g. oranges, lemons, grape-fruits or mandarins; vegetables, e.g. eggplant, spinach, lettuce (e.g. iceberg lettuce), chicory, cabbage, asparagus, cabbages, carrots, onions, garlic, leeks, tomatoes, potatoes, cucurbits or sweet peppers; lauraceous plants, e.g. avocados, cinnamon, or camphor; energy and raw material plants, e.g. corn, soybean, rapeseed, sugar cane or oil palm; tobacco; nuts, e.g. walnuts; pistachios; coffee; tea; bananas; vines; hop; sweet leaf (Stevia); natural rubber leaved trees or evergreens, eucalyptus; turf; lawn; grass. Preferred plants include potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rapeseed, legumes, sunflowers, coffee, or sugar cane; fruits; vines; ornamentals; or vegetables, e.g. cucumbers, tomatoes, beans or squashes. The term “seed” embraces seeds and plant propagules including true seeds, seed pieces, suckers, corms, bulbs, fruit, tubers, grains, cuttings, cut shoots, and means preferably true seeds. Plant is also described elsewhere herein. As used herein, "pesticidally effective amount" means the amount of active ingredient such as a compound of the present disclosure needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The pesticidally effective amount can vary for the various compound(s)/composition(s) used in the present disclosure. A pesticidally effective amount of the composition will also vary according to the prevailing conditions e.g. desired pesticidal effect and duration, weather, target species, locus, mode of application. For use in treating crop plants, e.g. by foliar application, the rate of application of the active ingredients of this invention may be in the range of 0.0001 g to 4000 g per hectare, e.g. from 1 g to 2 kg per hectare or from 1 g to 750 g per hectare, desirably from 1 g to 100 g per hectare. The compound of the present disclosure is also suitable for use against non-crop insect pests. For use against said non- crop pests, compound of the present disclosure can be used as bait composition, gel, general insect spray, aero-sol, as ultra-low volume application and bed net (impregnated or The term “non-crop insect pest” refers to pests, which are particularly relevant for non-crop targets, e.g. ants, termites, wasps, flies, ticks, mosquitoes, bed bugs, crickets, or cockroaches, such as: Aedes aegypti, Musca domestica, Tribolium spp.; termites such as Reticulitermes flavipes, Coptotermes formosanus ; roaches such as Blattella germanica, Periplaneta Americana·, ants such as Solenopsis invicta, Linepithema humile, and Camponotus pennsylvanicus. The bait can be a liquid, a solid or a semisolid preparation (e.g. a gel). For use in bait compositions, the typical content of active ingredient is from 0.001 wt% to 15 wt%, desirably from 0.001 wt% to 5 wt% of active compound. The compound of the present disclosure and its composition can be used for protecting wooden materials such as trees, board fences, sleepers, frames, artistic artifacts, etc. and buildings, but also construction materials, furniture, leathers, fibers, vinyl articles, electric wires and cables etc. from ants, termites and/or wood or textile destroying beetles, and for controlling ants and termites from doing harm to crops or human beings (e.g. when the pests invade into houses and public facilities or nest in yards, orchards or parks). Customary application rates in the protection of materials are, e.g., from 0.001 g to 2000 g or from 0.01 g to 1000 g of active compound per m 2 treated material, desirably from 0.1 g to 50 g per m 2 . Insecticidal compositions for use in the impregnation of materials typically contain from 0.001 to 95 wt%, preferably from 0.1 to 45 wt%, and more preferably from 1 to 25 wt% of at least one repellent and/or insecticide. Examples The present disclosure describes in more details with reference to the following Preparation Examples, Formulation Examples and Test Examples. However, the present disclosure is not limited to these Examples. In addition, alterations can be made within the scope that does not depart from the scope of the present disclosure. Reference Examples Preparation Example 1 Preparation of 2-(4-(tert-butyl)phenoxy)-5-(4-(3,5- dichloropyridin-2-yl)piperazine-1-carbonyl)-6- methylnicotinonitrile (IA-17) (1) Ethyl 5-cyano-2-methyl-6-oxo-1,6-dihydropyridine-3- carboxylate To ethyl 3-oxobutanoate (10.0 g, 76.92 mmol) was added 1,1-dimethoxy-N,N-dimethylmethanamine (10.3 mL, 85.83 mmol) maintaining the temperature between 0 to 10°C. The reaction mixture was allowed to stir at room temperature for 16h. Triethyl amine (940 mg, 9.3 mmol) was added to the reaction mixture followed by the addition of malononitrile (5.9 g, 89.83 mmol) in ethanol (50 mL). The reaction mixture was then stirred at room temperature for 16h. The reaction mixture was acidified with acetic acid (5.75 g, 96.16 mmol). A white solid precipitation appeared which was filtered and washed with distilled water. It was dried under reduced pressure to obtain white solid (12.0 g; Yield: 80%). 1 H NMR (DMSO-D 6 ): 12.98 (s, 1H), 8.44 (s, 1H), 4.22 (q, J = 6.8 Hz, 2H), 2.60 (s, 3H), 1.28 (t, J = 8.0 Hz, 3H). (2) Ethyl 6-chloro-5-cyano-2-methylnicotinate To a toluene (10 mL) solution of ethyl 5-cyano-2- methyl-6-oxo-1,6-dihydropyridine-3-carboxylate (6.5 g, mmol) at 10 °C, and the mixture was then refluxed for 16h. After distillation of toluene and excess phosphorous oxychloride, the residue was extracted with ethyl acetate (3 x 50 mL). The combined organic layer was washed with NaHCO 3 solution (3 x 50 mL), brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford ethyl 6-chloro-5-cyano-2-methylnicotinate as a brown solid (5.45 g, Yield 76.0%). This was used as such in the next step without any further purification. 1 H NMR (CDCl 3 ): 8.49 (s, 1H), 4.42 (q, J = 6.8 Hz, 2H), 2.90 (s, 3H), 1.42 (t, J = 7.2 Hz, 3H). (3) 6-Chloro-5-cyano-2-methylnicotinic acid To a tetrahydrofuran (20 mL) solution of ethyl 6-chloro- 5-cyano-2-methylnicotinate (3.5 g, 15.5 mmol) was added sodium hydroxide (560 mg, 13.99 mmol) dissolved in water (2 mL), and the mixture was then stirred at room temperature for 0.5h. It was then concentrated and the residue was extracted with ethyl acetate (3 x 50 mL). The combined organic layer was discarded. The aqueous layer was acidified with 2N HCl and extracted with ethyl acetate (3 x 50 mL), brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford 6-Chloro-5-cyano-2- methylnicotinic acid as an orange solid (2.80 g, Yield 90.0%). This was used as such in the next step without any further purification. 1 H NMR (CDCl 3 ): 8.60 (s, 1H), 2.95 (s, 3H). (4) tert-butyl 4-(3,5-dichloropyridin-2-yl)piperazine-1- carboxylate To a DMF (15 mL) solution of 2,3,5-trichloropyridine (1.5 g, 8.21 mmol) were sequentially added tert-butyl piperazine-1-carboxylate (1.84 g, 9.86 mmol) and potassium carbonate (3.4 g, 24.63 mmol) maintaining the temperature between 0 to 5°C. The reaction mixture was heated to 125 °C and water (80 mL) was added to it. It was extracted with diethyl ether (3 x 50 mL). The combined organic layer was washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford tert-butyl 4- (3,5-dichloropyridin-2-yl)piperazine-1-carboxylate as a colourless oil (2.6 g, Yield 95.0%). This was used as such in the next step without any further purification. 1 H NMR (CDCl 3 ): 8.12 (d, J = 2.4 Hz, 1H), 7.61 (d, J = 2.4 Hz, 1H), 3.57 (m, 4H), 3.27 (m, 4H), 1.48 (s, 9H). (5) 1-(3,5-dichloropyridin-2-yl)piperazine hydrochloride To a 1,4-dioxan (5 mL) solution of tert-butyl 4-(3,5- dichloropyridin-2-yl)piperazine-1-carboxylate (2.6 g, 7.83 mmol) was added dropwise 4N HCl in 1,4-dioxan solution (10 mL, 40.0 mmol) at room temperature and the reaction mixture was allowed to stir at room temperature for 2h. It was evaporated to dryness and triturated with diethyl ether (2 x 10 mL). This upon concentrated under reduced pressure afforded 1-(3,5-dichloropyridin-2-yl)piperazine hydrochloride as a white solid (2.0 g, Yield 95.0%). This was used as such in the next step without any further purification. 1H NMR (DMSO-D 6 ): 9.41 (bs, 2H), 8.32 (d, J = 2.4 Hz, 1H), 8.12 (d, J = 2.4 Hz, 1H), 3.47-3.49 (m, 4H), 3.19 (m, 4H). (6) 2-Chloro-5-(4-(3,5-dichloropyridin-2-yl)piperazine-1- carbonyl)-6-methylnicotinonitrile To 6-chloro-5-cyano-2-methylnicotinic acid (600 mg, 3.04 mmol) was added thionyl chloride (5 mL, 69.0 mmol) at room temperature and the reaction mixture was refluxed for 4h. It was evaporated to dryness and dissolved in anhydrous dichloromethane (10 mL). This was then added to 1-(3,5- dichloropyridin-2-yl)piperazine hydrochloride (983 mg, 3.65 mmol) followed by the addition of triethyl amine (1.1 mL, 9.12 mmol). The reaction mixture was then stirred at room pressure to afford a crude solid. This was purified by column chromatography (EtOAc:n-hexane = 1:4) to afford 2-chloro-5- (4-(3,5-dichloropyridin-2-yl) piperazine-1-carbonyl)-6- methyl-nicotinonitrile as a yellow solid (556 mg, Yield 44.0%). 1 H NMR (CDCl 3 ): 8.15 (d, J = 2.0 Hz, 1H), 7.81 (s, 1H), 7.83 (d, J = 2.4 Hz, 1H), 3.96 (m, 2H), 3.39-3.43 (m, 4H), 3.27 (m, 2H), 2.62 (s, 3H). (7) 2-(4-(tert-butyl)phenoxy)-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-methylnicotinonitrile To 2-chloro-5-(4-(3,5-dichloropyridin-2-yl) piperazine-1-carbonyl)-6-methyl-nicotinonitrile (130 mg, 0.31 mmol) were sequentially added 4-(tert-butyl)phenol (140 mg, 0.93 mmol) and sodium bicarbonate (104 mg, 1.24 mmol) at room temperature. The mixture was then heated at 135 °C for 6h. After cooling to room temperature, the reaction mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were then washed with 1N NaOH solution (3 x 20 mL), brine, dried over sodium sulfate. It was then filtered and concentrated under reduced pressure. The residue was then purified by column chromatography (EtOAc:n-hexane = 1:3) to afford 2-(4-(tert- butyl)phenoxy)-5-(4-(3,5-dichloropyridin-2-yl)piperazine-1- carbonyl)-6-methylnicotinonitrile (IA-17) as a yellow solid (140 mg, Yield 85%). 1 H NMR (CDCl 3 ): 8.14 (s, 1H), 7.80 (s, 1H), 7.64 (d, J = 2.0 Hz, 1H), 7.42 (d, J = 8.8 Hz, 2H), 7.10 (d, J = 6.4 Hz, 2H), 3.95 (m, 2H), 3.42 (m, 4H), 3.27 (m, 2H), 2.42 (s, 3H), 1.35 (s, 9H). Preparation Example 2 Preparation of 2-(4-(tert-butyl)phenoxy)-5-(4-(3,5- dichloropyridin-2-yl)piperazine-1-carbonyl)-6- isopropylnicotinonitrile (IA-55) (1) Ethyl 5-cyano-2-isopropyl-6-oxo-1,6-dihydropyridine-3- carboxylate Ethyl 4-methyl-3-oxopentanoate (10.0 g, 63.29 mmol) was taken in a reaction flask and to it added 1,1-dimethoxy-N,N- dimethylmethanamine (9.8 mL, 72.78 mmol) maintaining the temperature between 0 to 10°C. The reaction mixture was allowed to stir at room temperature for 16h. It was then concentrated to dryness. Freshly distilled THF (10 mL) was added to it. Sodium hydride (2.8 g, 69.61 mmol) was taken in another reaction flask in THF (30 mL). To it was added 2- cyanoacetamide (5.4 g, 63.29 mmol) and stirred at room temperature for 0.5h. Finally, the previous reaction mixture was transferred to this reaction mixture. The whole reaction mixture was stirred for 16h. The reaction mixture was quenched with ice-cooled water (5 mL) and acidified with 6N HCl. A white precipitation was appeared which was then filtered. It was dried under reduced pressure to afford ethyl 5-cyano-2-isopropyl-6-oxo-1,6-dihydropyridine-3-carboxylate as a white solid (12.0 g; Yield: 80%). 1 H NMR (DMSO-D 6 ): 12.23 (bs, 1H), 8.45 (s, 1H), 4.32 (q, J = 7.6 Hz, 3H), 1.37-1.57 (m, 9H). (2) Ethyl 6-chloro-5-cyano-2-isopropylnicotinate To a toluene (5 mL) solution of ethyl 5-cyano-2- isopropyl-6-oxo-1,6-dihydropyridine-3-carboxylate (4.0 g, 17.05 mmol) was added phosphorous oxychloride(10 mL, 107.0 mmol) at 10 °C, and the mixture was then refluxed for 12h. After distillation of toluene and excess phosphorous oxychloride, the residue was extracted with ethyl acetate (3 x 50 mL). The combined organic layer was washed with NaHCO 3 solution (3 x 50 mL), brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford ethyl 6-chloro-5-cyano-2-isopropylnicotinate as a light yellow solid (3.4 g, Yield 79.0%). This was used as such in the next step without any further purification. 253 (M+H, (3) 6-Chloro-5-cyano-2-isopropylnicotinic acid To a THF (20 mL) solution of ethyl 6-chloro-5-cyano-2- isopropylnicotinate (3.4 g, 13.43 mmol) was added sodium hydroxide (485 mg, 12.08 mmol) dissolved in water (2 mL) and the mixture was then stirred for 6h. It was then concentrated and the residue was extracted with ethyl acetate (3 x 50 mL). The combined organic layer was discarded. The aqueous layer was acidified with 2N HCl and extracted with ethyl acetate (3 x 70 mL), brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford 6-chloro-5- cyano-2-isopropylnicotinic acid as a light yellow solid (2.40 g, Yield 80.0%). This was used as such in the next step without any further purification. 1 H NMR (DMSO-D 6 ): 13.99 (s, 1H), 8.68 (s, 1H), 3.84-3.91 (m, 1H), 1.20 (d, J = 6.8 Hz, 6H). (4) 2-chloro-5-(4-(3,5-dichloropyridin-2-yl)piperazine-1- carbonyl)-6-isopropylnicotinonitrile To 6-chloro-5-cyano-2-isopropylnicotinic acid (400 mg, 1.77 mmol) was added thionyl chloride (5 mL, 69.0 mmol) at room temperature and the reaction mixture was refluxed for 4h. It was evaporated to dryness and dissolved in anhydrous dichloromethane (15 mL). This was then added to 1-(3,5- dichloropyridin-2-yl)piperazine hydrochloride (570 mg, 2.12 mmol) followed by the addition of triethyl amine (1.2 mL, 8.85 mmol). The reaction mixture was then stirred at room temperature for 4h. This upon concentrated under reduced pressure to afford a crude solid. The residue was then purified by column chromatography (ethyl acetate:n-hexane = 1:4) to afford 2-chloro-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-isopropylnicotinonitrile as an off-white solid (400 mg, Yield 51.0%). 1 H NMR (CDCl 3 ): 8.15 (d, J = 2.4 Hz, 1H), 7.76 (s, 1H), 7.65 (d, J = 2.4 Hz, 1H), 3.93-4.01 (m, 2H), 3.35-3.43 (m, 4H), (5) 2-(4-(tert-butyl)phenoxy)-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-isopropylnicotinonitrile (IA-55) To 2-chloro-5-(4-(3,5-dichloropyridin-2-yl)piperazine- 1-carbonyl)-6-isopropylnicotinonitrile (70 mg, 0.16 mmol) were sequentially added 4-(tert-butyl)phenol (96 mg, 0.63 mmol) and sodium bicarbonate (54 mg, 0.63 mmol) at room temperature. The mixture was then heated at 135 °C for 6h. After cooling to room temperature, the reaction mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were then washed with 1N NaOH solution (3 x 20 mL), brine, dried over sodium sulfate. It was then filtered and concentrated under reduced pressure. The residue was then purified by column chromatography (ethyl acetate:n-hexane = 1:3) to afford 2- (4-(tert-butyl)phenoxy)-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-isopropylnicotinonitrile (IA- 55) as an off-white solid (30 mg, Yield 35%). 1 H NMR (CDCl 3 ): 8.14 (d, J = 2.0 Hz, 1H), 7.76 (s, 1H), 7.63 (d, J = 2.4 Hz, 1H), 7.40 (d, J = 8.8 Hz, 2H), 7.13 (d, J = 9.6 Hz, 2H), 3.94-3.97 (m, 2H), 3.41-3.48 (m, 4H), 3.24-3.29 (m, 2H), 3.02-3.05 (m, 1H), 1.35 (s, 9H), 1.08 (d, J = 6.8 Hz, 6H). Preparation Example 3 Preparation of 2-((4-(tert-butyl)benzyl)oxy)-5-(4-(3,5- dichloropyridin-2-yl)piperazine-1-carbonyl)-6- methylnicotinonitrile (IA-48) To 2-chloro-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-methylnicotinonitrile (70 mg, 0.17 mmol) were sequentially added (4-(tert- butyl)phenyl)methanol (112 mg, 0.68 mmol) and sodium bicarbonate (57 mg, 0.68 mmol) at room temperature. The mixture was then heated at 135 °C for 6h. After cooling to (20 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were then washed with 1N NaOH solution (3 x 20 mL), brine, dried over sodium sulfate. It was then filtered and concentrated under reduced pressure. The residue was then purified by column chromatography (ethyl acetate:n-hexane = 1:3) to afford 2-((4-(tert- butyl)benzyl)oxy)-5-(4-(3,5-dichloropyridin-2-yl)piperazine -1-carbonyl)-6-methylnicotinonitrile (IA-48) as a white solid (89 mg, Yield 96%). 1 H NMR (CDCl 3 ): 8.14 (d, J = 2.4 Hz, 1H), 7.70 (s, 1H), 7.64 (d, J = 2.4 Hz, 1H), 7.39-7.44 (m, 4H), 5.49 (s, 2H), 3.95 (m, 2H), 3.40-3.42 (m, 4H), 3.26 (m, 2H), 2.53 (s, 3H), 1.33 (s, 9H). Preparation Example 4 Preparation of 2-((4-chlorophenyl)thio)-5-(4-(3,5- dichloropyridin-2-yl)piperazine-1-carbonyl)-6- methylnicotinonitrile (IA-14) To 2-chloro-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-methylnicotinonitrile (85 mg, 0.20 mmol) were sequentially added 4-chlorobenzenethiol (116 mg, 0.80 mmol) and sodium bicarbonate (67 mg, 0.80 mmol) at room temperature. The mixture was then heated at 135 °C for 6h. After cooling to room temperature, the reaction mixture was diluted with water (20 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were then washed with 1N NaOH solution (3 x 20 mL), brine, dried over sodium sulfate. It was then filtered and concentrated under reduced pressure. The residue was then purified by column chromatography (ethyl acetate:n-hexane = 1:3) to afford 2- ((4-chlorophenyl)thio)-5-(4-(3,5-dichloropyridin-2- yl)piperazine-1-carbonyl)-6-methylnicotinonitrile (IA-14) as an off-white solid (42 mg, Yield 40%). 1 H NMR (CDCl 3 ): 8.13 (d, J = 2.4 Hz, 1H), 7.65 (s, 1H), 7.64 (d, J = 2.0 Hz, 1H), 7.50 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H), 3.93 (m, 2H), 3.39 (m, 4H), 3.25 (m, 2H), 2.40 (s, 3H). Representative compounds of the present disclosure are exemplified in the following Tables 1-5, but the present disclosure is not limited to these compounds. The compounds shown in Tables 1-5, other than the compounds obtained in preparation examples 1 to 4, were produced by methods similar to the methods described in preparation examples 1 to 4 or methods described in the description. The abbreviations in Tables 1-5 are indicated as below: The abbreviations in Table 1 are as indicated below. F: fluoro, Cl: chloro, Br: bromo, I: iodo, Me: methyl, Et: ethyl, n-C 3 H 7 : n-propyl, t-Bu: tertiary butyl, c-C 6 H 11 : cyclohexyl, CF 3 : trifluoromethyl, SEt: ethylthio, SOEt: ethylsulfinyl, SO 2 Et: ethylsulfonyl, SCOMe: acetylthio, SCH 2 CF 3 : 2,2,2-trifluoroethylthio, SOCH 2 CF 3 : 2,2,2- trifluoroethylsulfinyl, SO 2 CH 2 CF 3 : 2,2,2- trifluoroethylsulfonyl, Me(R): methyl (R-isomer), Me(S): methyl (S-isomer). Table 1: Table 2: Table 3:

1 8 1 / 2 9 : 4 e l b a

1 8 1 / 3 9

1 8 1 / 4 9

1 8 1 / 5 9 1 8 1 / 6 9

1 8 1 / 7 9

1 8 1 / 8 9

1 8 1 / 9 9

1 8 1 / 0 0 1

1 8 1 / 1 0 1

1 8 1 / 2 0 1

1 8 1 / 3 0 1 Table 5:

Table 6: Detail and 1 H NMR of the compounds synthesized belonging to the Formula (I) of the present disclosure: ( )

Formulation Example 1: Emulsions 10 parts of each compound of the invention was dissolved in 45 parts of Solvesso ® 150 and 35 parts of N- methylpyrrolidone. 10 parts of an emulsifier (trade name: Sorpol ® 3005X, produced by Toho Chemical Industry Co., Ltd.) was added thereto. The mixtures were mixed by stirring to give 10% emulsions. Formulation Example 2: Wettable powders 20 parts of each compound of the invention was added to a mixture of 2 parts of sodium lauryl sulfate, 4 parts of sodium lignin sulfonate, 20 parts of fine powder of synthetic hydrated silicon dioxide, and 54 parts of clay. The mixtures were mixed by stirring with a juice mixer to give 20% wettable powders. Formulation Example 3: Granules 2 parts of sodium dodecylbenzenesulfonate, 10 parts of bentonite, and 83 parts of clay were added to 5 parts of each compound of the invention, and each mixture was sufficiently mixed by stirring. An appropriate amount of water was added thereto. The resulting mixtures were further stirred and granulated with a granulator. The granules were air-dried to give 5% granules. Formulation Example 4: Dusts 1 part of each compound of the invention was dissolved in an appropriate amount of acetone. 5 parts of fine powder of synthetic hydrated silicon dioxide, 0.3 parts of acidic isopropyl phosphate (PAP), and 93.7 parts of clay were added thereto. The mixtures were mixed by stirring with a juice mixer, and acetone was removed by evaporation to give 1% dust. Formulation Example 5: Flowable preparations 20 parts of each compound of the invention was mixed with 20 parts of water containing 3 parts of polyoxyethylene tristyrylphenyl ether phosphoric acid ester triethanolamine and 0.2 parts of Rhodorsil ® 426R. The mixtures were subjected to wet pulverization with a DYNO-Mill, and mixed with 60 parts of water containing 8 parts of propylene glycol and 0.32 parts of xanthan gum to give 20% suspensions in water. Test Examples are given below to demonstrate that the compounds of the invention are useful as an active ingredient for miticides. Test Example 1 (Miticidal test on two-spotted spider mite) Bioassay was conducted with a foliar spray test using the compound of the invention. Each compound was dissolved in acetone to 4000 ppm and diluted with deionized water (containing 100 ppm of Tween 80) when used. For an adult bioassay of two-spotted spider mite, about 20 adult females were transferred to 3 cm x 4 cm kidney bean leaf discs on wet cotton. After 24 h, after removal of the dead mite, leaf discs were sprayed with 4 mL of miticidal formulations containing the compound of the invention (100 ppm). After 3 days, mortality was determined. The compounds that exhibited the mortality rate of 80% or more are as follows: Compounds IA-5, IA-6, IA-17, IA-25, IA-34, IA-40, IA-42, IA- IA-79, IA-82, IA-85, IA-86, IA-87, IA-88, IA-89, IA-90, IA- 91, IA-93, IA-94, IA-95, IA-96, IA-97, IA-98, IA-99, IA-100, IA-101, IA-102, IA-103, IA-104, IA-105, IA-106, IA-107, IA- 108, IA-109, IA-110, IA-113, IA-116, IA-119, IA-122, IA-123, IA-124, IA-127, IA-128, IA-132, IA-134, IA-140, IA-148, IA- 150, IA-152, IA-153, IA-154, IA-157, IA-158, IA-160, IA-163, IA-166, IA-170, IA-171, IA-172, IA-173, IA-174, IA-175, IA- 176, IA-179, IA-181, IB-1, IB-2, IB-4, IB-6, IB-7, IB-8, IB- 9, IB-10, IC-1, IC-2, ID-1, ID-2, ID-3, ID-4, ID-5, ID-6, ID-7, ID-8, ID-9, ID-10, ID-11, ID-12, ID-13, ID-14, ID-15, ID-16, ID-17, ID-18, ID-21, ID-22, ID-23, ID-24, ID-25, ID- 26, ID-27, ID-28, ID-29, ID-30, ID-32, ID-33, ID-34, ID-35, ID-36, ID-37, ID-42, ID-43, ID-44, ID-45, ID-46, ID-47, ID- 48, ID-49, ID-50, ID-51, ID-52, ID-53, ID-54, ID-55, ID-56, ID-57, ID-58, ID-59, ID-60, ID-61, ID-62, ID-63, ID-64, ID- 65, ID-66, ID-67, ID-68, ID-73, ID-74, ID-75, ID-76, ID-77, ID-78, ID-79, ID-80, ID-81, ID-82, ID-83, ID-84, ID-85, ID- 86, ID-88, ID-90, ID-91, ID-92, ID-93, ID-94, ID-95, ID-96, ID-98, ID-99, ID-100, ID-101, ID-102, ID-103, ID-104, ID- 105, ID-106, ID-107, ID-108, ID-109, ID-110, ID-111, ID-112, ID-113, ID-114, ID-115, ID-116, ID-121, ID-122, ID-123, ID- 124, ID-125, ID-126, ID-128, ID-129, ID-130, ID-131, ID-132, ID-133, ID-135, ID-136, ID-137, ID-138, ID-139, ID-140, ID- 141, ID-142, ID-143, ID-144, ID-145, ID-146, ID-147, ID-148, ID-149, ID-150, ID-151, ID-152, ID-154, ID-155, ID-156, ID- 157, ID-158, ID-159, ID-161, ID-162, ID-164, ID-165, ID-166, ID-167, ID-168, ID-169, ID-170, ID-171, ID-172, ID-173, ID- 174, ID-175, ID-176, ID-177, ID-178, ID-179, ID-180, ID-181, ID-182, ID-183, ID-184, ID-185, ID-186, ID-187, ID-188, ID- 189, ID-190, ID-191, ID-192, ID-193, ID-194, ID-195, ID-196, ID-197, ID-198, ID-199, ID-200, ID-202, ID-204, ID-205, ID- 206, ID-208, ID-209, ID-210, ID-211, ID-212, ID-213, ID-214, ID-215, ID-216, ID-217, ID-219, ID-220, ID-221, ID-222, ID- 223, ID-224, ID-225, ID-226, ID-227, ID-228, ID-229, ID-230, ID-231, ID-232, ID-233, ID-234, ID-235, ID-236, ID-237, ID- 238, ID-239, IE-28, IE-29, IE-48, IE-51, IE-52, IE-55, IE- 56, IE-95, IE-104 and IE-105 Test Example 2 (Ovicidal test on Two-Spotted Spider Mites) Twenty adult females were transferred to 3 cm x 4 cm kidney bean leaf discs on wet cotton. Once egg laying was confirmed after 24 h, after removal of the adult mite, leaf discs were sprayed with 4mL of miticidal formulations containing the compound of the invention (100 ppm). After 7 days, mortality were determined. The compounds that exhibited the mortality rate of 80% or more are as follows: Compounds IA-17, IA-47, IA-49, IA-51, IA-52, IA-64, IA-67, IA-69, IA-79, IA-82, IA-85, IA-86, IA-87, IA-88, IA-89, IA- 90, IA-91, IA-93, IA-94, IA-95, IA-96, IA-97, IA-98, IA-99, IA-100, IA-101, IA-102, IA-103, IA-105, IA-106, IA-107, IA- 108, IA-109, IA-110, IA-113, IA-116, IA-119, IA-127, IA-128, IA-132, IA-134, IA-140, IA-143, IA-148, IA-150, IA-152, IA- 153, IA-154, IA-157, IA-158, IA-160, IA-163, IA-166, IA-171, IA-172, IA-173, IA-174, IA-175, IA-176, IA-177, IA-179, IA- 181, IB-1, IB-2, IB-4, IB-6, IB-7, IB-8, IB-9, IB-10, IC-1, IC-2, ID-1, ID-2, ID-3, ID-4, ID-5, ID-6, ID-7, ID-8, ID-9, ID-10, ID-11, ID-12, ID-13, ID-14, ID-15, ID-16, ID-17, ID- 18, ID-21, ID-22, ID-23, ID-24, ID-25, ID-26, ID-27, ID-28, ID-29, ID-32, ID-33, ID-34, ID-35, ID-36, ID-37, ID-38, ID- 39, ID-40, ID-41, ID-42, ID-43, ID-44, ID-45, ID-46, ID-47, ID-48, ID-49, ID-50, ID-51, ID-52, ID-53, ID-54, ID-55, ID- 56, ID-57, ID-58, ID-59, ID-60, ID-61, ID-62, ID-63, ID-64, ID-65, ID-66, ID-67, ID-68, ID-73, ID-74, ID-75, ID-76, ID- 77, ID-78, ID-79, ID-80, ID-81, ID-82, ID-83, ID-84, ID-85, ID-86, ID-90, ID-91, ID-92, ID-93, ID-94, ID-95, ID-96, ID- 98, ID-99, ID-100, ID-101, ID-102, ID-103, ID-104, ID-105, ID-106, ID-107, ID-108, ID-109, ID-110, ID-111, ID-112, ID- 113, ID-114, ID-115, ID-116, ID-121, ID-122, ID-123, ID-124, ID-125, ID-126, ID-127, ID-128, ID-129, ID-130, ID-131, ID- ID-141, ID-142, ID-143, ID-144, ID-145, ID-146, ID-147, ID- 148, ID-149, ID-150, ID-151, ID-152, ID-154, ID-155, ID-156, ID-157, ID-158, ID-159, ID-161, ID-162, ID-164, ID-165, ID- 166, ID-167, ID-168, ID-169, ID-170, ID-171, ID-172, ID-173, ID-174, ID-175, ID-176, ID-177, ID-178, ID-179, ID-180, ID- 181, ID-182, ID-183, ID-184, ID-185, ID-186, ID-187, ID-189, ID-190, ID-191, ID-192, ID-193, ID-194, ID-195, ID-196, ID- 197, ID-198, ID-199, ID-200, ID-204, ID-205, ID-207, ID-208, ID-209, ID-210, ID-211, ID-212, ID-213, ID-216, ID-217, ID- 218, ID-219, ID-220, ID-223, ID-224, ID-225, ID-226, ID-227, ID-228, ID-229, ID-230, ID-231, ID-232, ID-233, ID-234, ID- 235, ID-236, ID-237, ID-238, ID-239, IE-28, IE-29, IE-45, IE-48, IE-51, IE-52 and IE-104. Test Example 3 (Miticidal test on citrus red mite) Bioassay was conducted with a foliar spray test using the compound of the invention. Each compound was dissolved in acetone to 4000 ppm and diluted with deionized water (containing 100 ppm of Tween 80) when used. For an adult bioassay of citrus red mite, about 20 adult females were transferred to 3 cm x 4 cm citrus leaf discs on wet cotton. After 24 h, after removal of the dead mite, leaf discs were sprayed with 4 mL of miticidal formulations containing the compound of the invention (100 ppm). After 3 days, mortality was determined. The compounds that exhibited the mortality rate of 80% or more are as follows: Compounds IA-47, IA-64, IA-79, IA-87, IA-90, IA-108, IA- 109, IA-153, IA-157, IA-158, IA-160, IB-1, IB-4, IB-7, IB- 8, IC-1, ID-1, ID-2, ID-3, ID-4, ID-5, ID-6, ID-10, ID-12, ID-19, ID-20, ID-27, ID-28, ID-29, ID-32, ID-41, ID-44, ID- 45, ID-46, ID-47, ID-48, ID-49, ID-51, ID-56, ID-57, ID-58, ID-59, ID-60, ID-62, ID-63, ID-64, ID-70, ID-71, ID-72, ID- 73, ID-76, ID-77, ID-78, ID-83, ID-92, ID-93, ID-99, ID- 101, ID-102, ID-103, ID-104, ID-105, ID-106, ID-108, ID- 142, ID-144, ID-148, ID-149, ID-152, ID-156, ID-157, ID- 165, ID-173, ID-175, ID-180, ID-209, ID-211 and ID-232. Test Example 4 (Ovicidal test on citrus red mite) Twenty adult females of citrus red mite were transferred to 3 cm x 4 cm citrus leaf discs on wet cotton. Once egg laying was confirmed after 24 h, after removal of the adult female mite, leaf discs were sprayed with 4mL of miticidal formulations containing the compound of the invention (100 ppm). After 7 days, mortality were determined. The compounds that exhibited the mortality rate of 80% or more are as follows: Compound IA-47, IA-64, IA-109, IA-153, IA-160, IA-176, IB- 4, IB-7, IB-8, IC-1, ID-1, ID-3, ID-4, ID-5, ID-6, ID-10, ID-12, ID-19, ID-20, ID-23, ID-27, ID-28, ID-29, ID-32, ID- 43, ID-44, ID-45, ID-46, ID-51, ID-55, ID-56, ID-57, ID-59, ID-60, ID-66, ID-70, ID-71, ID-80, ID-83, ID-85, ID-92, ID- 93, ID-99, ID-101, ID-102, ID-103, ID-105, ID-106, ID-107, ID-108, ID-110, ID-122, ID-123, ID-127, ID-148, ID-149, ID- 156, ID-157, ID-175, ID-180, ID-198, ID-200, ID-209, ID-211, ID-232, IE-29 and IE-56. (Note) As described above, the Examples are illustrated by preferable embodiments of the present disclosure. However, it will be understood that the scope of the present disclosure should be interpreted only by the claims. It is understood that patents, patent applications and literatures cited herein are incorporated herein by reference, as if the contents thereof are specifically described herein. The present application claims priority to Indian Application No. 202011042327 filed on September 29, 2020 with the Indian Patent Office (Intellectual Property India), the entire content of which is incorporated herein by reference. Industrial applicability The piperazine compound of the present disclosure shows an excellent controlling effect against a wide range of pests such as mites and is useful as a miticide agent for agricultural and horticultural use.